序号,label,cleaned_text
1,Liver_Cancer,ace enhances sensitivity pd l blockade inhibiting macrophage induced immunosuppression angiogenesis anti pd l based combination immunotherapy become first line treatment unresectable hepatocellular carcinoma hcc however objective response rate lower highlighting need identify mechanisms tolerance immune checkpoint inhibitors accurate biomarkers response study used next generation sequencing analyze hcc samples patients receiving anti pd l therapy activation renin angiotensin system elevated nonresponders compared responders angiotensin converting enzyme ace expression significantly downregulated nonresponders ace deficiency promoted hcc development anti pd l resistance whereas ace overexpression inhibited hcc progression immune competent mice mass cytometry time flight revealed ace deficient
2,Liver_Cancer,intermittent hypoxia alleviates increased vegf pro angiogenic potential cells vascular endothelial growth factor vegf important angiogenic factor vegf rebound induced hypoxia following transarterial embolization chemoembolization primary associated treatment failure poor survival rates patients present study investigated ability intermittent hypoxia alleviate acute hypoxia induced increase vegf decrease pro angiogenic potential cells cells exposed normoxia acute intermittent hypoxia expression vegf determined using reverse transcription quantitative polymerase chain reaction analysis western blotting pro angiogenic effects acute intermittent hypoxia exposed cells endothelial cells assessed vitro vivo expression vegf cells exposed intermittent hypoxia significantly lower cells exposed acute hypoxia compared conditioned
3,Liver_Cancer,adjuvant transarterial chemoembolization influence recurrence free overall survival patients combined hepatocellular carcinoma cholangiocarcinoma curative resection propensity score matching analysis prognosis patients combined hepatocellular carcinoma intrahepatic cholangiocarcinoma chc usually poor effective adjuvant therapy missing making important investigate whether patients may benefit adjuvant transarterial chemoembolization tace aimed evaluate efficiency adjuvant tace long term recurrence survival curative resection propensity score matching psm analysis retrospective study patients underwent resection chc january december patients received adjuvant tace univariate multivariate regression analyses used identify independent predictive factors survival cox regression analyses log rank tests used compare overall survival os disease free survival
4,Liver_Cancer,age specific features clinical significance nrf mapk expression hcc patients abstracttext label background nlmcategory background nuclear factor erythroid derived like nrf functions decline age however cells hijack pathways ensure survival aggressiveness yet role nrf hepatocellular carcinoma hcc rarely investigated age specific manner study investigates expression nrf activator mapk different age groups hcc patients addition age specific features nrf mapk interaction clinical significance abstracttext abstracttext label methods nlmcategory methods tumor near tumor tissue samples hcc patients used complete protein expression analysis nrf mapk patients survival clinical data collected clinical analysis global databases tcga icgc used collect mapk
5,Liver_Cancer,studies organellae bearing animals ii catalase activity animals treated cyto plasmic organellae hepatoma cell ah cell hepatoma bearing animals author studied distribution polysaccharides amino acid composition cytoplasmic organellae problems come call great interest field studies bearing animals also biochemical electron microscopic observations carried study influences cytoplasmic organellae cells ah livers bearing animals normal catalase activity results obtained follows cytoplasmic organellae various cells affect markedly hexose metabolism amino acid pattern cytoplasmic organellae various cells studied paperchromatography interesting note pattern bearing animals shows lack histidine er tissue bearing animals increase phenylalanine observed decrease catalase activity caused primary factor
6,Liver_Cancer,high intratumoral metastasis associated colon expression predicts poor outcomes cryoablation therapy advanced hepatocellular carcinoma cryoablation one local therapies hepatocellular carcinoma hcc safety effect studied patients child class b barcelona clinic bclc stage c hcc metastasis associated colon macc overexpression associated poor prognosis hcc predictive value post cryoablation outcomes remains unknown patients bclc stage c hcc study assessed safety outcomes cryoablation measured time progression ttp overall survival os predictive value macc mrna protein overexpression tumorous tissue post cryoablation outcomes advanced hcc patients child pugh class b quantitative polymerase chain reaction immunohistochemical staining potenial correlation macc c met
7,Liver_Cancer,tissue infiltrating lymphocytes signature predicts survival patients early intermediate stage hepatocellular carcinoma intratumoral immune infiltrates manifested robust prognostic signature patients hepatocellular carcinoma hcc hypothesized novel tissue related immune signature tris could improve prediction postoperative survival patients diagnosed early intermediate hcc twenty eight immune features immunohistochemically examined hcc specimens lasso cox regression model used construct five feature based tris univariate multivariate cox analyses performed based independent predictors immune clinical prognostic index icpi established performance assessment measured c index compared seven traditional staging systems independent validation cohort n included validate model using lasso method tris constructed basis five
8,Liver_Cancer,pexpression analyses key members rdgn tissues benign hepatic diseases human abstract aim analyze differences expression dach different groups diseases cirrhosis fatty chronic hepatitis study relationship clinical pathological features stage pathologic grade type age gender expression dach six main members retinal determination gene network rdgn explore correlation among dach six cyclind tissues methods expression dach one tissue microarray including cases different hepatic diseases expression dach six cyclind another tissue microarray including cases normal detected immunohistochemical methods one way anova chi square test orderly logistic regression used data analysis results cirrhosis fatty chronic hepatitis groups dach expression lower
9,Liver_Cancer,incidence saudi arabia decreasing trend leading cause mortality morbidity worldwide existing data burden saudi arabia limited therefore study aimed analyze incidence mortality trends saudi arabia two decades compare regional worldwide data incidence data saudi arabia collected national registry reports study period additionally global regional data burden obtained world health organization international agency research iarc global observatory website saudi arabia revealed relatively lower burden compared global rates males showed decreasing trend age standardized incidence rates study period females displayed steady rates incidence males nearly doubled compared females male female ratio additionally significant regional variations incidence observed across
10,Liver_Cancer,associating partition portal vein ligation staged hepatectomy colorectal metastasis single center experience abstracttext label background nlmcategory unassigned associated partition portal vein ligation staged hepatectomy alpps increasingly used treatment primarily unresectable colorectal metastases crlm insufficient future remnant flr aim study share experience alpps advanced crlm review role alpps management patients crlm abstracttext abstracttext label methods nlmcategory unassigned consecutive patients n crlm underwent alpps center december october retrospectively studied abstracttext abstracttext label results nlmcategory unassigned median age patients years range years five patients metachronous crlm patients synchronous crlm five patients unilateral crlm patients bilateral crlm patients previously underwent
11,Liver_Cancer,synthetic mir mimics delivered tumor exosomes repress hepatocellular carcinoma downregulating lymphoid enhancer factor abstracttext label background nlmcategory background dysregulation exosomal micrornas plays important role progression hepatocarcinogenesis study investigated therapeutic potential synthetic exosomal mir hcc cells explored feasibility tumor derived exosomes drug delivery vehicles abstracttext abstracttext label methods nlmcategory methods proliferation migration assays performed examine effects mir hcc vitro direct target gene mir identified mirecords analysis target validation transferring efficiency anti hcc effect exosomes different origin studied optimal mir delivery method established verified vitro vivo addition relationships prognosis hcc patients mir expression hcc serum exosomes retrospectively analyzed
12,Liver_Cancer,spatial immunophenotypes predict clinical outcome intrahepatic cholangiocarcinoma abstracttext label background amp aims nlmcategory unassigned intrahepatic cholangiocarcinoma icca severe malignant tumour shows modest responses immunotherapy aimed identify spatial immunophenotypes icca delineate potential immune escape mechanisms abstracttext abstracttext label method nlmcategory unassigned multiplex immunohistochemistry mihc performed quantitatively evaluate distribution immune cell subsets intratumour invasive margin peritumour areas cohort treatment na patients icca multiregion unsupervised clustering used determine three spatial immunophenotypes multiomics analyses carried explore functional differences b results b icca displayed region specific distribution immune cell subsets abundant cd sup sup neutrophil infiltration intratumour areas three spatial immunophenotypes
13,Liver_Cancer,nomogram models predicting risk prognosis newly diagnosed ovarian patients metastases large population based real world study b background b previous studies metastases lm newly diagnosed ovarian ndoc patients based surveillance epidemiology end results seer program disregarded selection bias missing data b methods b identified data ndoc patients seer presented comprehensive description dataset limited possible biases due missing data applying multiple imputation mi determined predictive factors underlying lm development ndoc patients evaluated prognostic factors ndoc patients lm oclm established predictive nomograms assessed concordance index calibration curve decision curve analysis dca clinical impact curves cic b results b
14,Liver_Cancer,predicting risk using comprehensive medical history abstracttext label background objectives mortality rising faster significantly impacting life expectancy due relatively young median age diagnosis high mortality rate currently consistently recommended screening tests individuals high risk profile abnormalities body systems disease cirrhosis study aims screen various body system diseases might associated risk abstracttext abstracttext label methods study utilized us database including us based adults aged least absolute shrinkage selection operator regression logistic regression used identify significant predictors calculate odds ratios ors statistical analyses conducted using r software abstracttext abstracttext label results total participants diagnoses male gender white race
15,Liver_Cancer,autophagy activation hepatocellular carcinoma contributes tolerance oxaliplatin via reactive oxygen species modulation purpose understanding roles mammalian autophagy highlights recent advances pharmacologic manipulation autophagic pathways therapeutic strategy however autophagy status corresponding functions hepatocellular carcinoma hcc therapeutic stress remain clarified study determine whether autophagic machinery could activated chemotherapy contribution autophagy tolerance oxaliplatin hcc experimental design autophagy activation cell death induced oxaliplatin examined two hcc cell lines well vivo using hcc model nude mice hcc tissue samples without locoregional chemotherapy surgery also examined immunohistochemical electron microscopic analysis results autophagy functionally activated hcc cell lines xenografts oxaliplatin treatment suppression autophagy
16,Liver_Cancer,knockdown lncrna linc suppresses tumorigenesis via sponging mir p background frequent malignancy poor prognosis high mortality world reported many lncrnas could modulate tumorigenesis identify novel potential targets differential expressed lncrnas adjacent normal tissues analyzed bioinformatics tool methods differential expressed lncrnas adjacent normal tissues analyzed bioinformatics tool cell viability proliferation tested cck ki respectively apoptosis cells tested flow cytometry gene protein expressions cells measured qrt pcr western blot respectively vivo model established detect effect linc vivo results linc found negatively correlated survival rate patients moreover knockdown linc significantly suppressed proliferation invasion cells via inducing apoptosis meanwhile mir
17,Liver_Cancer,evaluation midkine diagnostic serum biomarker hepatocellular carcinoma purpose evaluate value serum midkine mdk diagnostic biomarker hepatocellular carcinoma particularly negative alpha fetoprotein afp early stage experimental design mdk expression tumors assessed immunohistochemistry patients hepatocellular carcinomas cirrhosis serum mdk levels detected elisa participants including hepatocellular carcinomas hospital controls different medical centers sensitivities specificities serum mdk diagnosing hepatocellular carcinoma according afp level barcelona clinic bclc stage analyzed results mdk levels significantly elevated hepatocellular carcinoma tissues well serum samples sensitivity serum mdk hepatocellular carcinoma diagnosis much higher afp vs similar specificities vs notably serum mdk outstanding performance distinguishing afp negative
18,Liver_Cancer,fmo associated fibroblasts sensitize anti pd therapy patients hepatocellular carcinoma abstracttext label background nlmcategory background efficacy immune checkpoint inhibitors icis hepatocellular carcinoma hcc limited heterogeneity individual responses therapy heterogeneous phenotypes crucial roles associated fibroblasts cafs immunotherapy resistance remain largely unclear abstracttext abstracttext label methods nlmcategory methods specific caf subset identified integrating comprehensive single cell rna sequencing spatial transcriptomics transcriptome profiling patients hcc different responses antiprogrammed cell death protein anti pd therapy mouse orthotopic hcc models coculture system constructed cytometry time flight analysis performed investigate functions mechanisms specific cafs immune context hcc abstracttext abstracttext label results nlmcategory
19,Liver_Cancer,metastases detected intraoperatively indicates worse prognosis colorectal metastases patients resection combined microwave ablation abstracttext label background nlmcategory unassigned whether tumor numbers detected surgery compared preoperative image affecting survival colorectal metastases crlm patients hepatectomy combined microwave ablation mwa remains unclear abstracttext abstracttext label methods nlmcategory unassigned crlm patients underwent hepatectomy combined mwa retrospectively assessed compared tumor numbers preoperative image patients equal intraoperative tumor numbers defined equal number group n patients detected tumor numbers surgery defined number group n clinicopathological factors prognosis compared two groups abstracttext abstracttext label results nlmcategory unassigned compared equal number group number group characterized
20,Liver_Cancer,association disease condition changes intestinal flora plasma endotoxin vascular endothelial growth factor levels patients objective currently therapeutic effect patients associated disease development meanwhile efficacy patients advanced far satisfactory therefore aim study explore association disease condition changes function indexes intestinal flora plasma endotoxin et vascular endothelial growth factor vegf levels patients patients methods total patients primary hospital enrolled study patients divided three groups including early group middle group advanced group peripheral blood collected subject detect function indexes procalcitonin pct plasma et vegf levels furthermore mid posterior segment stools collected cases group sent company detection intestinal flora results
21,Liver_Cancer,hepatoscan ensemble classification learning models disease detection jats p dangerous disease poses significant risks human health complexity early detection increases due unpredictable growth cells paper introduces hepatoscan ensemble classification detect diagnose tumors datasets proposed hepatoscan integrated approach classifies three types hepatocellular carcinoma cholangiocarcinoma angiosarcoma initial stage starts second stage spreads parts body deep learning emerging domain develops advanced learning models detect diagnose early stages train pre trained model inceptionv datasets identify advanced patterns associated tumors cells accurate segmentation classification lesions computed tomography ct scans ensemble multi class classification emcc combines u net mask region based convolutional
22,Liver_Cancer,nuclear matrix protein alterations associated colon metastasis purpose development colon markers detect metastases early predict patients risk develop metastases would major impact disease previously identified g brunagel et al research nuclear matrix proteins nmps associated colon objective study identify existence specific nmp fingerprint human metastasis colon experimental design using high resolution two dimensional gel electrophoresis analyzed nmp expression matched metastases adjacent normal samples three normal donor samples compared colon nmp patterns along several primary cell systems lines results analysis multiple gels sample revealed three proteins present metastases present normal tissue normal hepatocytes three proteins also present
23,Liver_Cancer,data circrpn inhibits aerobic glycolysis metastasis hepatocellular carcinoma jats p lt div gt abstract lt p gt although circular rnas circrna known modulate tumor initiation progression role hepatocellular carcinoma hcc metastasis remains poorly understood three metastasis associated circrnas identified previous circrna sequencing study screened validated two hcc cohorts circrpn downregulated highly metastatic hcc cell lines hcc tissues metastasis patients hcc lower circrpn levels displayed shorter overall survival higher rates cumulative recurrence mechanistic studies lt gt vitro lt gt lt gt vivo lt gt revealed circrpn binds enolase eno accelerates degradation promote glycolytic reprogramming akt mtor pathway
24,Liver_Cancer,obesity obesity related metabolic disorders become globally prevalent posing challenge chronically damaged predisposing development progression rising phenomenon obesity epidemic may provide means understanding one malignancies rising incidence developed countries last decades non alcoholic fatty disease associated obesity insulin resistance type diabetes increasingly recognized trigger western populations characterized low prevalence established risk factors viral hepatitis hepatotoxin exposure accumulating evidence established association higher body mass index indicator general obesity higher risk primary associations stronger men patients underlying disease white ethnic groups abdominal obesity weight gain adult life metabolic factors related visceral fat accumulation also suggested important risk factors
25,Liver_Cancer,screening identification molecular marker metastatic metastastic carcinoma also called secondary refers tumor transferred parts body portal vein hepatic artery lymph metastatic generally lung mammary gland colon pancreas stomach well leukemia hemocyte said stomach pancreatic colon could transferred portal vein breast lung could transferred hepatic artery generally speaking metastatic free hbv infection hepatitis hepatocirrhosis afp normal cea raised per ct detection various focal nodes found inside may suffer necrobiosis cystic degeneration bleeding calcification generally metastatic merged portal vein embolus well defined symptoms found early phase case symptoms occur pathological changes obvious early phase mainly reflects symptom primary
26,Liver_Cancer,nccn newsnew reliable source free information people gallbladder bile duct offered nccnnccn convenes summit providing high quality care evolving policy tech landscape new reliable source free information people gallbladder bile duct offered nccnnccn released brand new resource help people gallbladder bile duct better understand critical decisions make care new edition nccn guidelines patients takes evidence based expert consensus treatment recommendations nccn clinical practice guidelines oncology nccn guidelines creates patient friendly version easy follow wording funding provided nccn foundation sponsorship global institute content endorsed cholangiocarcinoma foundation essential element patient empowerment accessible actionable high quality information said donna
27,Liver_Cancer,albumin alkaline phosphatase ratio independent prognostic indicator combined hepatocellular cholangiocarcinoma background clinical significance albumin alkaline phosphatase ratio aapr discussed hepatocellular carcinoma hcc cholangiocarcinoma cc aim study clarify prognostic value aapr patients combined hepatocellular cholangiocarcinoma chcc cca methods total patients pathologically diagnosed allen type c chcc cca institution retrospectively enrolled randomly divided training n cohort validation n cohort prognostic value aapr evaluated validated aapr based nomogram constructed prediction performance assessed results identified optimal threshold value aapr x tile software training cohort median overall survival os patients aapr significant shorter aapr months vs months respectively p univariate multivariate
28,Liver_Cancer,significance expression shp stem cell objective study expression shp stem cells significance stem cells regulation clarify molecular mechanism shp regulating stem cells explore feasibility therapeutic target biomarkers individualized treatment methods real time pcr used detect expression shp chemotherapy resistant hcc cells xenografts addition expression shp detected real time pcr technique stem cell enriched hcc cells using variety sorting techniques interfering shp cell line used define possible regulation mechanism shp stem cells western blot method results vivo experiments showed shp expression increased chemotherapy resistant xenografts vitro experiments expression shp elevated stem cells expression shp closely related b
29,Liver_Cancer,inducible models transgenic zebrafish investigate biology primary one prevalent deadly incidence continues increase treatment response remains poor thus depth understanding tumour events necessary develop effective therapies animal models powerful tools reach goal past decade laboratory established multiple oncogene transgenic zebrafish lines robustly induced develop histological transcriptomic molecular analyses validate use transgenic zebrafish experimental models review provide comprehensive summary findings inducible zebrafish models tumour initiation oncogene addiction tumour microenvironment gender disparity cachexia drug screening others induced oncogene expression causes rapid change tumour microenvironment inflammatory responses increased vascularisation rapid hepatic growth several models histologically proven carcinoma induced within
30,Liver_Cancer,worse outcome sorafenib therapy associated ascites child pugh score advanced hepatocellular carcinoma background aim outcomes sorafenib therapy patients advanced hepatocellular carcinoma hcc impaired function remain unresolved although child pugh cp classification widely used patient categorization heterogeneity within given cp class makes outcomes less predictable aim investigate prognostic significance cp score elements outcome sorafenib patients advanced hcc impaired function methods consecutive patients advanced hcc center january december reviewed medical records patients received sorafenib monotherapy results median duration sorafenib months range median follow months range disease control rates significantly higher cp class cpa cp class b cpb patients
31,Liver_Cancer,family history increases risk incidence year prospective cohort study qidong china objective evaluate whether first degree family history plays role incidence prospective evaluation patient cohort qidong china year period methods may hepatitis b surface antigen hbsag carriers hbsag negadve controls qidong city enrolled participation prospective cohort study ending november follow carried every months evaluations included serum assays measure concentrations alpha fetoprotein afp hbsag alanine aminotransferase alt well abdominal ultrasound assess disease relationship baseline study entry information patients first degree family history incidence two decades study statistically assessed results newly diagnosed cases cohort person years py follow
32,Liver_Cancer,upregulation gtpbp promotes proliferation cells research background public health issue worldwide ranks second related mortality rates worldwide china mortality rate ranks second among types five year survival rate five year survival rate surgery exceed recurrence rate surgery high therefore research occurrence progression mechanism still urgent research method explore expression gtpbp patients gepia oncomine ualcan databases relationship gtpbp gene expression overall survival patients explored kaplan meier plotter database string database protein interacting gtpbp found subsequently expression gtpbp gene mrna level protein level cells verified fluorescence quantitative pcr western blotting experiments cck experiment effect gtpbp gene expression growth
33,Liver_Cancer,morc novel oncogene upregulated contributes proliferation metastasis chemoresistance microrchidia morc important dna damage repair lipogenesis however clinical functional role morc remains fully elucidated aim present study clarify role morc expression profile analysis immunohistochemical staining reverse transcription quantitative polymerase chain reaction analysis western blot analysis performed evaluate levels morc patient specimens cell lines subsequently expression morc suppressed increased cells effects morc cancerous transformation cells examined vitro vivo morc upregulated tissues upregulation associated certain clinicopathologic features patients morc knockdown caused marked inhibition cell proliferation clonogenicity whereas overexpression morc substantially promoted cell proliferation addition knockdown morc inhibited migratory invasive
34,Liver_Cancer,integrated single cell bulk sequencing analysis identifies tumor reactive cxcr cd cells predictor immune infiltration immunotherapy outcomes hepatocellular carcinoma abstracttext label background nlmcategory unassigned various immune cell types tumor microenvironment tme hepatocellular carcinoma hcc identified important parameters associated prognosis responsiveness immunotherapy however various factors influence immune cell infiltration remains incompletely understood hence investigated single cell multi omics landscape immune infiltration hcc particularly key gene cell subsets influence immune infiltration thus potentially linking immunotherapy response immune cell infiltration abstracttext abstracttext label methods nlmcategory unassigned grouped patients hcc according immune cell infiltration scores calculated single sample gene set
35,Liver_Cancer,expressions hif kiss patients correlation analysis objective study expressions hypoxia inducible factor hif tumor metastasis suppressor gene kiss patients analyze correlation hif kiss patients methods normal tissues tissues hospital selected expressions hif kiss normal tissues tissues detected via immunofluorescence assay mrna expressions hif kiss normal tissues tissues detected via reverse transcription polymerase chain reaction rt pcr protein expressions hif kiss normal tissues tissues detected via western blotting differences hif kiss expressions normal tissues tissues analyzed using spss statistical software results immunofluorescence assay rt pcr western blotting showed hif highly expressed tissues expression level significantly higher normal
36,Liver_Cancer,inhibition autophagy macrophage promotes il mediated hepatocellular carcinoma progression via inflammasome accumulation self recruitment hepatocellular carcinoma hcc complex changeable tumor microenvironment despite emerging evidence focusing autophagy process within immune cells function regulatory mechanism macrophage autophagy tumor progression remains unclear results multiplex immunohistochemistry rna sequencing identified reduced levels autophagy tumor macrophages hcc microenvironment associated poor prognosis increased microvascular metastasis hcc patients specifically hcc suppressed macrophage autophagy initiation regulation mtor ulk phosphorylation ser knockdown autophagy related proteins inhibit autophagy significantly boosted metastatic potential hcc mechanistically accumulation nlrp inflammasome mediated autophagy inhibition promoted cleavage maturation release il facilitated hcc
37,Liver_Cancer,impact lymph node dissection prognosis patients intrahepatic cholangiocarcinoma jats p jats bold e jats bold jats p jats p jats bold background jats bold intrahepatic cholangiocarcinoma icc makes radical resection sole potential cure lymph node metastasis key prognostic factor however routine lymph node dissection necessity debated clinical evidence role impact icc limited study explores routine lymph node dissection effects focusing non metastatic lymph node removal jats bold methods jats bold analyzed clinical prognostic data icc patients underwent resection excluding combined hepatocellular cholangiocarcinoma preoperative extrahepatic metastases neoadjuvant therapy patients divided group dissection n group ii dissection negative
38,Liver_Cancer,platelet lymphocyte ratio predicts tumor response survival patients hepatocellular carcinoma undergoing immunotherapies abstracttext label background nlmcategory background lymphocyte related factors associated survival outcome different types nevertheless association lymphocytes related factors tumor response immunotherapy remains unclear abstracttext abstracttext label methods nlmcategory methods retrospective study eligible participants included patients unresectable advanced hepatocellular carcinoma hcc underwent immunotherapy first line treatment radiological assessment tumor response adhered recist hcc specific modified recist mrecist criteria univariate multivariate logistic analyses employed analyze clinical factors associated tumor response kaplan meier survivial analysis employed compare progression free survival pfs overall survival os across different clinical
39,Liver_Cancer,disease burden thyroid chinese population objective analyze disease burden chinese population methods data global burden diseases gbd used analyze disease burden china main outcome measurements would include mortality disability adjusted life years daly gbd global standard population used reference population calculate age standardized rate related changes percentage calculated analyze changing patterns disease burden china results total people died crude death rate china number deaths due secondary hepatitis b accounting number deaths due secondary hepatitis c accounting daly due appeared million person years leading causes daly related secondary hepatitis b followed secondary hepatitis c secondary alcohol use
40,Liver_Cancer,cordycepin mediates pyroptosis hcc upregulation txnip synergizes anti pd l immunotherapy abstracttext label background nlmcategory background immune checkpoint inhibitors effective treatments hcc however therapeutic efficacy often limited development drug resistance therefore investigating new combination therapeutics involving immune checkpoint inhibitors critical improving patient prognosis study investigated therapeutic effect cordycepin cor hcc synergistic effect anti programmed cell death ligand anti pd l immunotherapy abstracttext abstracttext label methods nlmcategory methods selected hcc cell lines investigate effects cor hcc growth using vivo vitro experiments performed rna sequencing mhcc h cell line treated without cor understand underlying mechanism identify key regulatory
41,Liver_Cancer,surgical treatment primary report cases objective summarize experience surgical treatment primary methods clinical data surgically managed cases primary january december hepatobiliary center first affiliated hospital nanjing medical university retrospectively analyzed life table method used calculate survival rate postoperative recurrence rate log rank test used compare survival process different groups cox regression model used multivariate analysis addition cases hepatocellular carcinoma hcc detailed follow data selected survival analysis among patients treated hepatectomy males females age years range years among patients treated transplantation males females age years range years outcomes hepatectomy versus transplantation anatomic versus non anatomic hepatectomy compared
42,Liver_Cancer,predictive value neutrophil lymphocyte ratio recurrent hcc repeat hepatectomy salvage transplantation abstracttext label backgrounds aims nlmcategory objective hepatocellular carcinoma hcc prevalent type primary characterized high rate recurrence study aims compare efficacy safety repeat hepatectomy rh salvage transplantation slt recurrent hepatocellular carcinoma rhcc explores predictive value neutrophil lymphocyte ratio nlr neutrophil extracellular traps nets abstracttext abstracttext label methods nlmcategory methods study consecutive patients receiving rh n slt n rhcc within university california san francisco ucsf criteria recruited propensity score matching psm disease free survival dfs overall survival os compared utilizing kaplan meier method additionally level neutrophil infiltration
43,Liver_Cancer,demethylation mir upregulates expression membrane palmitoylated proteins promotes apoptosis cells background common main cause related deaths worldwide sixth common world although mir palmitoyl membrane palmitoylated protein mpp reportedly involved various cell processes precise roles still unclear aim investigate expression micro rna mir methylation mir promoter expression mpp cells related mechanisms methods together cases tissues cases adjacent tissues collected methylation degree mir promoter paracancerous tissue cells normal cells expression levels mir mpp samples detected demethylation cells transfection cells mir mimetic performed mpp overexpression vector used transfect cells changes proliferation invasion apoptosis migration biological functions cells interventions observed
44,Liver_Cancer,supplementary material burden trends primary caused specific etiologies global regional national age sex level results global burden disease study b background b one leading causes related deaths worldwide primary causes include hepatitis b virus hbv hepatitis c virus hcv alcohol consumption nonalcoholic fatty disease factors b aims b objective study evaluate global sex age region country etiology related burden well trends caused different etiologies b methods b causes including global regional national incidence mortality etiology collected global burden disease study time dependent change trends burden evaluated annual percentage change b results b global incidence mortality increasing
45,Liver_Cancer,mir inhibits malignant biological behavior human cells regulating srpk although treatment made great progress mechanism occurrence completely clear mir plays important regulatory role tumorigenesis development including survival proliferation migration invasion however role regulatory mechanism mir rarely reported analyzed mir expression tissue samples cell lines qrt pcr expression mir measured qrt pcr mir mimic sh mir transfection cck clonogenic assays used detect proliferation cells cell scratch invasion assays used detect migration invasion rna seq used detect difference rna expression cells srpk expression detected cells transfection qrt pcr western blotting observed mir downregulated tissues compared normal tissues furthermore
46,Liver_Cancer,research mechanism gastrodin treatment based network pharmacology jats p objective remains major cause mortality rising incidence worldwide gastrodin bioactive compound gastrodia elata shown anti potential study applied bioinformatics analyses identify specific pharmacological targets gastrodin examining roles methods data normal tissue gastrodin retrieved multiple databases including genecards herb tcmsp datasets analyzed using venny interactivenn metascape integrative analysis visualization metascape used enrichment analysis protein protein interaction ppi network construction gene ontology go kyoto encyclopedia genes genomes kegg pathways cytoscape facilitated detailed functional network visualization results intersected genes among tissue gastrodin identified via venn analysis key targets obtained including
47,Liver_Cancer,laparoscopic versus open left hemihepatectomy hepatocellular carcinoma propensity score matching analysis abstracttext label background nlmcategory background despite increasing application laparoscopic hepatectomy lh hepatocellular carcinoma hcc laparoscopic left hemihepatectomy llh remains relatively rare surgery comparison perioperative oncological outcomes llh open left hemihepatectomy olh lacking abstracttext abstracttext label methods nlmcategory methods total hcc patients underwent either llh olh january november enrolled retrospective observational study propensity score matching psm performed llh olh groups abstracttext abstracttext label results nlmcategory results patients llh group smaller tumor size p earlier tnm staging p matching despite similar transfusion rate matching patients undergoing llh
48,Liver_Cancer,lrp mutations promote tumor progression resistance anti pd therapy recurrent hepatocellular carcinoma abstracttext label background aims nlmcategory objective hcc recurrence major factor limiting long term survival cause deaths patients hcc however molecular characterization potential therapeutic targets recurrent hcc remain mostly unknown abstracttext abstracttext label approach results nlmcategory results performed whole exome sequencing matched primary recurrent hcc tumors combined data whole genome sequencing results paired samples previous study sanger sequencing used identify low density lipoprotein receptor related protein lrp coding exons additional patients recurrent hcc identified lrp somatic mutations recurrent tumors primary tumors p lt prognosis second
49,Liver_Cancer,shogaol suppresses progression via inactivation wnt formula see text catenin signaling regulating tlr gastrointestinal malignant tumor high lethality prognosis remains poor compounds derived natural products confirmed alleviate progression various diseases including additionally shogaol reported induce apoptosis cells however mechanism shogaol regulates apoptosis cells remains unclear investigate function shogaol rt qpcr western blotting used detect expression tlr foxo cells respectively od value cells measured using mtt assay flow cytometry used measure cell apoptosis shogaol inhibited growth cells tlr wnt formula see text catenin upregulated cells foxo inactivated shogaol reversed expression tlr wnt formula see text catenin foxo
50,Liver_Cancer,metastatic human hepatocellular carcinoma models nude mice cell line metastatic potential metastatic human hcc model needed studies mechanism intervention metastatic recurrence using orthotopic implantation histologically intact tissues surgical specimens patient like metastatic model human hcc nude mice lci low metastatic model human hcc nude mice lci established mice transplanted lci tumors exhibited extremely high metastatic ability including spontaneous metastasis lungs lymph nodes peritoneal seeding remarkable difference also found expression invasiveness related genes growth factors lci lci tumors pai increased gradually following tumor progression lci model correlated tumor size afp level phasic expression tissue intercellular adhesion molecule
51,Liver_Cancer,abstract overexpression potential oncogenic micrornas defines new molecular subclass hepatocellular carcinoma jats title abstract jats title jats p background hepatocellular carcinoma hcc common form third cause related death worldwide incidence increasing mainly due hepatitis c virus hcv infection molecular classification hcc still lacking micrornas mirnas small non coding rna involved hcc pathogenesis expression profiling represents powerful tool classify jats p jats p objectives provide mirna based molecular classification hcc investigate function potential oncogenic mirnas hcc models jats p jats p methods expression mirnas analyzed hcv related hccs using bead based mirna expression profiling method integrative analysis
52,Liver_Cancer,trends major risk factors korea republic korea hereafter korea one countries high incidence great difference incidence male female investigated sex specific trends three major risk factors hepatitis b virus hbv infection hepatitis c virus hcv infection alcoholic cirrhosis incidence obtained registration statistics national center korea hepatitis b surface antigen hbsag seropositivity based data korea national health nutrition examination survey disease statistics health insurance review assessment service korea used evaluate trends hcv infection alcoholic cirrhosis prevalence risk factors compared incidence males three four times higher incidence females gap incidence males females increased age males aged showed five
53,Liver_Cancer,epidemic characteristics spatiotemporal pattern etiologic factors burden china retrospective analysis title abstract title p background rising prevalence obesity increasing alcohol consumption advances hepatitis virus treatment epidemiology gradually changes however impact changes burden china remains unclear study aimed assess temporal trends burden across whole country province level administrative regions contributions various etiologies china methods age standardized incidence death rate evaluated according sex age etiology using data global burden disease study related age standardized rates province level administrative regions china obtained national central registry results increase incidence death respectively age standardized incidence death rate remained stable south china
54,Liver_Cancer,inflamed non inflamed classes hcc revised immunogenomic classification abstracttext label objective previously reported characterisation hepatocellular carcinoma hcc immune contexture described immune specific class aim delineate immunogenomic classification hcc incorporate features explain responses resistance immunotherapy abstracttext abstracttext label design performed rna whole exome sequencing cell receptor tcr sequencing multiplex immunofluorescence immunohistochemistry novel cohort hcc patients validated results cohorts comprising patients abstracttext abstracttext label results integrative analysis led define inflamed class hcc includes previously reported immune subclass new immune like subclass high interferon signalling cytolytic activity expression immune effector cytokines diverse cell repertoire gene signature able capture tumours
55,Liver_Cancer,sqstm p intrahepatic cholangiocarcinoma promotes tumor progression via epithelial mesenchymal transition mitochondrial function maintenance abstracttext label background sqstm p selective autophagy receptor regulates multiple signaling pathways participating initiation progression tumors metastasis still main cause intrahepatic cholangiocarcinoma icc associated mortality hence study aimed explore mechanism p promoting progression icc abstracttext abstracttext label methods western blotting immunohistochemical analyses conducted detect expression level protein p icc tissues correlation prognosis subsequently loss function experiments vitro vivo performed define role p icc cell proliferation invasion metastasis effect p knockdown mitochondrial function mitophagy evaluated measuring oxygen consumption rate using immunofluorescence western blotting
56,Liver_Cancer,comparison transarterial chemoembolization radiofrequency ablation unresectable barcelona clinic stage hepatocellular carcinoma propensity score matching background aim radiofrequency ablation rfa recommended one standard treatments early hepatocellular carcinoma hcc high risk tumor locations unfit rfa transarterial chemoembolization tace served alternative option settings define role tace early hcc retrospectively compared efficacies tace rfa patients unresectable barcelona clinic bclc stage hcc materials methods treatment naive patients unresectable bclc stage hcc underwent tace rfa recruited patients underwent tace patients underwent rfa included final analysis using propensity model correct selection bias patients selected treatment arm cumulative overall survival os primary end point
57,Liver_Cancer,prediction using machine learning enhancing early detection survival analysis jats p still one lethal world consistently increasing rates united states caused rising rates obesity rates hepatitis infection disease associated alcohol early detection crucial improving patient survival typically found advanced stages dismal survival rates treatment choices overall objective study create test machine learning models diagnosis survival prediction research focused machine learning u health system using patient data different demographic clinical backgrounds dataset study rich patient dataset collected great care support machine learning model development detection survival prediction detailed patient demographic data including age gender ethnicity geographic origin
58,Liver_Cancer,inflammatory pseudotumor associated malignant disease report two cases review literature two cases inflammatory pseudotumor ipt associated gastrointestinal tract reported addition etiological correlation ipt abscesses patients discussed first patient year old woman underwent distal gastrectomy partial hepatectomy diagnosis stomach metastasis second patient year old man undergone surgery rectal years previously underwent partial hepatectomy diagnosis metastasis rectal gastric papillary adenocarcinoma limited mucosa rectal moderately differentiated adenocarcinoma limited subserosa resected tumor first case measured cm cm second cut surface showed masses well circumscribed divided lobules fibrous tissue yellowish white color evidence necrosis hemorrhage histologically masses consisted fibrous areas cellular
59,Liver_Cancer,combined application preoperative serum cea ca ca levels metastasis colorectal objective study application value preoperative serum cea ca ca prediction metastasis colorectal methods total patients colorectal underwent surgery hospital chinese academy medical sciences january january enrolled study among patients colorectal metastases included observation group case matched patients colorectal without metastases included control group preoperative serum carcinoembryonic antigen cea carbohydrate antigen ca carbohydrate antigen ca measured patients univariate multivariate analysis tumor markers used alone combination study results results univariate multivariate analysis showed increased preoperative serum cea ca ca significantly correlated metastases patients colorectal p sensitivity cea ca
60,Liver_Cancer,laparoscopic vs open resection malignancies involving segment short term outcomes learning curve analysis using propensity score matching abstracttext label background nlmcategory background many studies demonstrated feasibility laparoscopic resection llr however short term outcomes malignancies located involving couinaud segment appraised compared open resection olr addition impact llr learning curve surgical outcomes sites remains unclear abstracttext abstracttext label methods nlmcategory methods single institution retrospective study included patients underwent resection malignancies involving segment propensity score matching balanced llr n olr n cohorts surgical outcomes compared llr learning curve conversions plotted via risk adjusted cumulative sum ra cusum analysis abstracttext
61,Liver_Cancer,prognostic significance microrna hepatocellular carcinoma updated meta analysis jats sec jats title background jats title jats p recently microrna found abnormally expressed hepatocellular carcinoma however clinical value summarised meta analysis aimed assess prognostic significance mir hepatocellular carcinoma jats p jats sec jats sec jats title material methods jats title jats p pubmed science direct web science scopus ovid medline embase google scholar cochrane library cnki cbm vip wanfang databases searched eligible articles endpoints included overall survival progression free survival recurrence free survival metastasis free survival disease free survival hazard ratios confidence intervals used explore relationship mir
62,Liver_Cancer,optimal time tumour response evaluation effectiveness hypofractionated proton beam therapy inoperable recurrent hepatocellular carcinoma tae hyun kim joong park bo hyun kim dae yong kim sung ho moon sang soo kim ju hee lee sang myung woo young hwan koh woo jin lee chang min kim center research institute hospital national center goyang korea authors contributed equally work correspondence tae hyun kim email k onco naver com keywords hepatocellular carcinoma tumour response proton beam therapy received june accepted november published december abstract objective evaluate optimal time tumour response effectiveness hypofractionated proton beam therapy pbt hepatocellular carcinoma
63,Liver_Cancer,e enhances lenvatinib antitumor activity preclinical models human hepatocellular carcinoma abstracttext label purpose nlmcategory unassigned aberrant activation catenin ctnnb occurs hepatocellular carcinomas hcc associated immune evasion limited response immunotherapy however remains undruggable target study studied antitumor antiangiogenic activity combining e oral protein protein interaction inhibitor targeting creb binding protein cbp catenin lenvatinib elucidated novel mechanism action e boosts antitumor response abstracttext abstracttext label experimental design nlmcategory unassigned generated genetically engineered ctnnb mutant murine hcc model randomized animals receive vehicle e lenvatinib combination n arm evaluated survival analyzed tumors transcriptomically ihc also analyzed five patient derived organoids
64,Liver_Cancer,application circulating tumor dna prediction surveillance tumor recurrence transplantation pilot study jats p e jats p jats p background emerging data suggest circulating tumor dna ctdna could detect minimal residual disease mrd reflect tumor recurrence radical resection hepatocellular carcinoma hcc however reported ctdna measurements based hotspot mutations predictive value transplantation lt still undetermined conducted pilot study investigate ctdna fingerprint detection marker mrd hcc patients undergoing lt methods enrolled patients hcc monitored ctdna changes along course treatment pre post operation serial sampling peripheral blood patents treated lt ctdna variations used assess recurrence analyzed correlation ctdna levels recurrence
65,Liver_Cancer,abo blood groups prospective results hbsag cohort study objective association abo blood group risk unclear although studies reported positive results study examined relationship abo blood group hepatitis b surface antigen hbsag positive individuals design high risk population based cohort study setting study started closed number observed person years obtained abo blood group participants study included individuals positive hbsag including men aged women aged outcome measures frequencies abo group cohort population patients calculated respectively test used compare differences relative risk ci development evaluated results frequency distribution blood types b ab respectively among cohort individuals cohort patients n
66,Liver_Cancer,alcohol consumption major risk factor rise mortality rates japanese men background age adjusted mortality rates increasing men women japan since however increases mortality rates men much greater women hepatitis c virus infections heavy alcohol consumption considered major risk factors deaths japanese purpose study examine pattern mortality gender birth year compare pattern alcohol related mortality estimate attributable risk per cent heavy alcohol consumption deaths japanese men methods age specific mortality rates gender compared cirrhosis mortality rates male female mortality rate ratios calculated birth cohort compared cirrhosis mortality rate ratios oesophageal mortality rate ratios attributable risk per cent
67,Liver_Cancer,multiomics analysis reveals metabolic subtypes identifies diacylglycerol kinase dgka potential therapeutic target intrahepatic cholangiocarcinoma abstracttext label background intrahepatic cholangiocarcinoma icca highly heterogeneous lethal hepatobiliary tumor therapeutic strategies metabolic reprogramming tumor cells plays essential role development tumors metabolic molecular classification icca largely unknown performed integrated multiomics analysis metabolic classification depict differences metabolic characteristics icca patients hoping provide novel perspective understand treat icca abstracttext abstracttext label methods performed integrated multiomics analysis icca samples including whole exome sequencing bulk rna sequencing proteome analysis based non negative matrix factorization method protein abundance metabolic genes human genome scale metabolic models metabolic
68,Liver_Cancer,mortalin stabilizes cd depedent tetraspanin enriched microdomains implicates progression hepatocellular carcinoma background previous studies showed tetraspanin cd implicated progression hepatocellular carcinoma hcc mainly depending formation functional complexes molecular partners including mortalin study investigate role mortalin cd depedent progression hccs methods immunofluorescent staining western blot quantitative real time polymerase chain reaction qrt pcr used investigate expression location cd mortalin four hcc cell lines different metastatic ability relationship mortalin cd investigated hcclm cells using co immunoprecipitation cd mortalin expression hcc cells modified transfection technology wound healing assay transwell assay used assay role cd mortalin cell migration invasion expression
69,Liver_Cancer,efficacy safety lenvatinib preventing tumor recurrence transplantation hepatocellular carcinoma beyond milan criteria abstracttext label background nlmcategory unassigned lenvatinib one first line treatments unresectable hepatocellular carcinoma hcc however data lacking lenvatinib postoperative setting abstracttext abstracttext label methods nlmcategory unassigned retrospective analysis enrolled patients hcc underwent transplantation ltx eligible patients divided groups according use adjuvant lenvatinib following ltx lenvatinib n control n primary outcome measures overall survival os time recurrence ttr safety kaplan meier analysis applied calculate os competing risk model used estimate cumulative incidence recurrence abstracttext abstracttext label results nlmcategory unassigned lenvatinib group showed advanced tumors higher
70,Liver_Cancer,clinical efficacy safety sintilimab plus anlotinib unresectable intrahepatic cholangiocarcinoma icc prospective single arm phase ii study jats p e jats p jats p background intrahepatic cholangiocarcinoma icc second common primary malignancy immunotherapy plus chemotherapy regimen top az study demonstrated important therapeutic advantages icc severe aes reaction chemotherapy might deteriorate treatment compliance performance status quality life even subsequent treatment eligibility hence unmet need tolerable regimen comparable efficacy patients unresectable icc clinical benefits combining sintilimab anlotinib reported variety clinical studies solid tumors non small cell lung hepatocellular carcinoma trial aims explore safety efficacy sintilimab plus anlotinib unresectable icc
71,Liver_Cancer,abstract phase ib ii open label study evaluating efficacy safety toripalimab injection js combination lenvatinib neoadjuvant therapy patients resectable hepatocellular carcinoma hcc jats title abstract jats title jats p background standard care neoadjuvant adjuvant therapy resectable hepatocellular carcinoma hcc yet trial designed explore safety efficacy toripalimab toripalimab combination lenvatinib peri operative treatment hcc nct jats p jats p methods ongoing phase ib ii trial patients pts hcc eligible surgical resection enrolled neoadjuvant part study pts arm given toripalimab mg iv single dose pts arm b treated toripalimab mg iv plus concurrent lenvatinib mg daily orally based
72,Liver_Cancer,development deep pathomics score predicting hepatocellular carcinoma recurrence transplantation abstracttext label background purpose nlmcategory objective tumor recurrence transplantation lt impedes curative chance hepatocellular carcinoma hcc patients study aimed develop deep pathomics score dps predicting tumor recurrence transplantation using deep learning abstracttext abstracttext label patients methods nlmcategory methods two datasets hcc patients underwent lt enrolled residual convolutional neural networks used identify six histological structures hcc individual risk score structure dps derived modified deepsurv network cox regression analysis concordance index used evaluate prognostic significance cellular exploration prognostic immune biomarkers performed quantitative spatial proximity analysis according three panels color
73,Liver_Cancer,pck aldh identified biomarkers inherent drug resistance hepatocellular carcinoma abstracttext label background nlmcategory background hepatocellular carcinoma hcc major cause related deaths worldwide often diagnosed advanced stages limited treatment options despite advancements systemic therapies including use lenvatinib survival rate advanced hcc remains low due drug resistance tumor heterogeneity abstracttext abstracttext label method nlmcategory methods study employed single cell sequencing spatial transcriptomics investigate intra tumor heterogeneity identify subpopulations malignant cells inherent drug resistance tumor samples obtained patients undergoing lenvatinib differential analysis performed identify biomarkers associated drug resistance abstracttext abstracttext label results nlmcategory results analysis revealed significant differences treatment
74,Liver_Cancer,metagenomic next generation sequencing versus traditional laboratory methods diagnosis treatment infection transplantation abstracttext label background metagenomic next generation sequencing mngs emerged effective method noninvasive precise detection infectious pathogens however data lacking whether mngs analyses could used diagnosis treatment infection perioperative period patients undergoing transplantation lt abstracttext abstracttext label methods february october conducted exploratory study using mngs traditional laboratory methods tms including culture serologic assays nucleic acid testing pathogen detection pairs cadaveric donors corresponding recipients method performance determining presence perioperative infection guiding subsequent clinical decisions compared mngs tms abstracttext abstracttext label results percentage donors mngs positive pathogen
75,Liver_Cancer,combined ensemble model cem detection system one important organs human body proper function critical overall health diseases disorders serious consequences also known hepatic divided various types cells belong common type hepatocellular carcinoma hcc hcc one common types affect people worldwide early detection essential healthcare increases chances successful treatment patient outcomes many researchers developed models help detect diagnose first step detecting identifying people higher risk chronic hepatitis b c infection cirrhosis heavy alcohol use obesity exposure certain chemicals toxins risk factors paper mainly focused detecting affected regions occur paper combined ensemble model cem detection system developed find
76,Liver_Cancer,study stage factor korea introduction social drinking pervasive culture south korea perceived necessary workplace also well known unlikely discovered time prognosis unfavorable well highly placed registration ranking therefore necessary identify difference survival rate depending stages patients design future differentiated approaches treatment nursing could applied patients accordance methods study aims analyze proportion patients diagnosed hepatocellular carcinoma gender figure difference survival rate accordance stages results distribution patients depending stages higher males females stages especially case stage terminal males accounted largest proportion besides mortality rate stage highest regarding mortality rate distribution also turned likely patients dead without complications co
77,Liver_Cancer,identification glycolysis related molecular subtypes prognostic model intrahepatic cholangiocarcinoma abstracttext label background nlmcategory background intrahepatic cholangiocarcinoma icca second common primary tumor notable high heterogeneity glycolysis plays critical role tumorigenesis progression drug resistance across various malignancies therapeutic implications targeting glycolysis remain underexplored study aims identify glycolysis related molecular subtypes explore functional heterogeneity develop prognostic model icca abstracttext abstracttext label methods nlmcategory methods consensus clustering based glycolysis related prognostic genes performed classify icca patients functional enrichment analyses revealed key biological pathways associated tumor progression gene risk model aldh b ddit gale hk hmmr pgam pgk plod sap constructed
78,Liver_Cancer,prognostic value systemic immune inflammation index patients unresectable hepatocellular carcinoma treated immune based therapy abstracttext label background nlmcategory background predicting efficacy immune based therapy patients unresectable hepatocellular carcinoma hcc remains clinical challenge study aims evaluate prognostic value systemic immune inflammation index sii forecasting treatment response survival outcomes hcc patients undergoing immune based therapy abstracttext abstracttext label methods nlmcategory methods analyzed cohort hcc patients treated immune based therapy january march training cohort patients received atezolizumab plus bevacizumab validation cohort patients underwent treatment tyrosine kinase inhibitors tkis combined anti pd l therapy sii cutoff value determined using x
79,Liver_Cancer,graft pd l predictive marker rejection pd inhibitor therapy recurrent tumors transplant prospective pilot trial safety immunotherapy patients undergoing transplant remains unclear due rejection risks study assessed safety efficacy programmed death pd inhibitors patients recurrent tumors undergone transplantation emphasizing value using graft programmed death ligand expression predictor rejection guide patient selection single center open label prospective single arm study conducted july may zhongshan hospital fudan university shanghai china eligible participants included patients recurrent metastatic undergone transplantation unresponsive locoregional systemic therapies primary endpoints incidence clinical outcomes acute rejection secondary endpoints overall survival objective response rate twenty consecutive
80,Liver_Cancer,toripalimab combined lenvatinib gemox promising regimen first line treatment advanced intrahepatic cholangiocarcinoma single center single arm phase study advanced intrahepatic cholangiocarcinoma icc dismal prognosis report efficacy safety combining toripalimab lenvatinib gemcitabine plus oxaliplatin gemox first line therapy advanced icc thirty patients pathologically confirmed advanced icc received intravenous gemcitabine g sup sup days oxaliplatin mg sup sup q w six cycles along intravenous toripalimab mg q w oral lenvatinib mg daily one year expression programmed death ligand pd l genetic status investigated paraffin embedded tissues using immunohistochemistry whole exome sequencing wes analysis primary endpoint objective response rate
81,Liver_Cancer,phase ii iii study camrelizumab plus apatinib perioperative treatment resectable hepatocellular carcinoma intermediate high risk recurrence primary results major pathologic response phase ii stage jats p jats p jats p background surgical resection remains important treatment strategy patients pts however year recurrence rate still surgically resectable pts intermediate high risk factors recurrence hcc include single tumor size gt cm multiple tumors microvascular invasion standardized perioperative regimen resectable hcc established study aimed assess efficacy safety camrelizumab plus apatinib c perioperative regimen resectable hcc intermediate high risk recurrence clinical trial nct methods multicentre randomised phase ii iii study
82,Liver_Cancer,research progress alpha fetoprotein induced immunosuppression one common malignant tumors limited treatment mortality fourth leading cause related deaths seriously endangers human life health approximately patients show increased serum alpha fetoprotein afp levels afp main diagnostic prognostic indicator afp key marker plays crucial role regulating proliferation tumor cells apoptosis induction cellular immune escape high levels afp embryonic development protect embryos maternal immune attack afp also promotes immune escape cells inhibiting tumor infiltrating lymphocytes tils natural killer cells nk dendritic cells dc macrophages thus also used target antigen immunotherapy afp highly expressed cells addition used diagnosis become target
83,Liver_Cancer,pkc zfp csf axis resets tumor microenvironment fuels anti pd resistance hepatocellular carcinoma abstracttext label background amp aims despite remarkable advances treatment patients hepatocellular carcinoma hcc respond poorly anti programmed cell death anti pd therapy deeper insight tolerance mechanism hcc therapy urgently needed abstracttext abstracttext label methods performed next generation sequencing multiplex immunofluorescence dual color immunohistochemistry constructed orthotopic hcc xenograft tumor model identify key gene associated anti pd tolerance spontaneously tumorigenic transgenic mouse model vitro coculture system mass cytometry multiplex immunofluorescence used explore biological function zinc finger protein zfp tumor progression immune escape molecular biochemical strategies
84,Liver_Cancer,targeting hedgehog pathway hepatocellular carcinoma abstractunchecked activity cell signaling pathway crucial embryonic development response injury leads researchers duke university medical center johns hopkins university school medicine found pathway called hedgehog present immature stem like cells discovery offers hope targeted treatment one leading causes related death world laboratory experiments show blocking hedgehog pathway kills cells leaves mature healthy cells intact researchers report treating patients medications interrupt pathway would likely eliminate cells sparing healthy tissue said jason sicklick postdoctoral fellow duke lead author study currently good chemotherapies many people advanced disease ill surgery remove tumors sicklick said desperate
85,Liver_Cancer,effective antiviral therapy improves immunosuppressive activities immune microenvironment hepatocellular carcinoma alleviating inflammation fibrosis abstracttext label background aims nlmcategory objective immune microenvironment ime plays crucial role progression hepatocellular carcinoma hcc hcc ime often compromised hepatitis b virus hbv infection chronic inflammation fibrosis antiviral therapy avt alleviation inflammation fibrosis aif shown improve prognosis however relationship among ime hcc avt aif remains unclear abstracttext abstracttext label methods nlmcategory methods total primary hbv related hcc patients enrolled training validation sets respectively establish hcc immune microenvironment score h ime score immunohistochemistry performed assess number granzyme b grb foxp cells well expression
86,Liver_Cancer,expressions significances golgi mannosidase ii e cadherin normal tissue tissues objective investigate expressions significances golgi mannosidase gm e cadherin normal tissue tissues methods expressions gm e cadherin mrnas normal tissue highly lowly differentiated tissues determined rt pcr proteins sp immunohistochemical assay western blot based differential expressions gm e cadherin analyzed correlation results rt pcr western blot showed expression levels gm mrna protein low normal tissue high moderately lowly differentiated tissues moderate highly differentiated tissues however expressions e cadherin contrary gm sp immunohistochemical assay showed gm mainly expressed cytoplasma normal tissue tissue positive rates normal tissue highly
87,Liver_Cancer,intratumoral ppt positive macrophages determine immunosuppressive contexture immunotherapy response hepatocellular carcinoma abstracttext label background hepatocellular carcinoma hcc malignancy limited treatment options poor prognosis macrophages enriched hcc microenvironment significant impact disease progression therapy efficacy aim identify critical macrophages subsets involved hcc development abstracttext abstracttext label methods macrophage specific marker genes identified single cell rna sequencing analyses clinical significance macrophages palmitoyl protein thioesterase ppt positive investigated patients hcc zhongshan hospital using immunohistochemistry immunofluorescence immune microenvironment hcc functional phenotype ppt sup sup macrophages explored using cytometry time flight cytof rna sequencing abstracttext abstracttext label results single cell rna sequencing
88,Liver_Cancer,functional genomic complexity defines intratumor heterogeneity tumor aggressiveness abstract background chronic inflammation chromosome aneuploidy major traits primary plc represent second common cause related death worldwide increased fitness aggressiveness plc may achieved enhancing tumoral genomic complexity alters tumor biology method developed scoring method namely functional genomic complexity fgc determine degree molecular heterogeneity among tumors diverse ethnicities etiologies assessing integrated genomic transcriptomic data results found tumors higher fgc scores associated chromosome instability tp mutations worse prognosis tumors lower fgc scores elevated infiltrating lymphocytes better prognosis results indicate fgc scores may serve surrogate define genomic heterogeneity plc linked chromosomal
89,Liver_Cancer,exosome depleted mir p derived hepatic stellate cells promotes tumor progression via itga pi k akt axis hepatocellular carcinoma hepatocellular carcinoma hcc major cause related death worldwide although known hepatic stellate cells hscs play critical roles development progression hcc molecular mechanism underlying crosstalk hscs cells still remains unclear investigated interactions hscs cells indirect co culture system expressions cellular exosomal mir p evaluated quantitative real time pcr cell counting kit used evaluating cell growth vitro cell migration invasion ability evaluated wound healing transwell assays western blot quantitative real time pcr luciferase reporter assay performed determine target gene
90,Liver_Cancer,immune related gene signature predicting prognosis immunotherapy response hepatocellular carcinoma abstracttext label background hepatocellular carcinoma hcc inflammation associated high incidence poor prognosis last decade immunotherapy become important strategy managing hcc abstracttext abstracttext label objective study aimed establish immune related gene signature predicting prognosis immunotherapy response hcc abstracttext abstracttext label methods identified immune related differentially expressed genes irdegs based genome atlas tcga database immunology database analysis portal immport database weighted gene co expression network analysis wgcna cox proportional hazard model utilized determine hub immune related genes irgs tide tool r package prrophetic used assess correlation immune related
91,Liver_Cancer,comprehensive analysis complement associated molecular features hepatocellular carcinoma complement cascade plays complementing role human immunity however potential roles complement system impacting molecular clinical features hepatocellular carcinoma hcc remain unclear study eleven public datasets analyzed compare complement status normal cancerous samples based classical complement associated genes complement scores constructed quantify complement signatures individual tumors hcc patients genome atlas tcga cohort focused perform systematical analyses complement status immune infiltration mirna expression dna methylation clinicopathological features drug response results show complement scores normal tissues dramatically higher tumor tissues tumor samples tcga cohort classified complement score low score high groups
92,Liver_Cancer,associating partition portal vein ligation staged hepatectomy unresectable hepatitis b virus related hepatocellular carcinoma single center study patients objective aim study assess efficacy safety associating partition portal vein ligation staged hepatectomy alpps patients hepatitis b virus related hepatocellular carcinoma hcc background alpss allows curative resection conventionally unresectable tumors however role hcc largely unknown methods consecutive hcc patients underwent alpps center april september retrospectively studied oncological results compared patients receiving transcatheter arterial chemoembolization tace patients undergoing one stage resection using propensity score matching psm analysis results median tumor diameter cm range cm patients single tumor n whereas
93,Liver_Cancer,relations new long non coding rna uc kfo metastasis objective investigate expression new long non coding rna incrna uc kfo relations invasion metastasis methods collect cases cirrhosis tissue samples cases tissue samples cases samples tissues near cases samples tissues portal vein transferred situ hybridization method used test expression uc kfo acta gene smooth muscle actin tissues results results situ hybridization indicate uc kfo expressed expressed low quantity cirrhosis group expressed positively tissues tissues near portal vein transferred tissues expression values four groups respectively variance analysis shows differences uc lkfo expression statistically significance p differences four groups
94,Liver_Cancer,dissecting intra tumoral changes following immune checkpoint blockades intrahepatic cholangiocarcinoma via single cell analysis abstracttext label purpose dissect tumor ecosystem following immune checkpoint blockades icbs intrahepatic cholangiocarcinoma icc single cell level abstracttext abstracttext label methods single cell rna sequencing scrna seq data icc patients icb clinical trial extracted gse systematically reanalyzed bulk rna seq data icc patients analyzed infiltration levels spp sup sup cd sup sup tumor associated macrophages tams examined dual immunofluorescence staining resected icc samples correlation spp sup sup tams clinicopathological features well prognostic significance evaluated abstracttext abstracttext label results among patients five received
95,Liver_Cancer,new nomogram predicts recurrence hepatocellular carcinoma patients negative preoperative serum afp subjected curative resection background currently established model predicting recurrence hepatocellular carcinoma hcc patients negative alpha fetoprotein afp curative resection therefore objective study establish nomogram identify risk recurrence afp negative ng ml patients hcc methods retrospective study conducted establish recurrence free survival rfs nomogram training cohort afp negative hcc patients results validated well matched validation cohort literature results macrovascular tumour invasion p hr macronodular cirrhosis p hr tumor size p hr glutamyl transferase p hr found independent risk factors rfs training cohort factors included nomogram c
96,Liver_Cancer,proximal resection margins prognostic distal resection margins patients undergoing hilar cholangiocarcinoma resection purpose even though therapeutic gold standard hilar cholangiocarcinoma hcca resection free resection margin rm surgical treatment still remains challenging study evaluated prognostic significance rm status resected hcca patients identified survival prognostic factors materials methods reviewed records hcca patients underwent surgery analyzed rm status prognostic factors affecting survival results negative rm n significantly associated better survival vs positive rm n mean survival time mst months vs months p margins histological findings non dysplastic epithelium low grade dysplasia carcinoma situ associated survival differences mst months vs
97,Liver_Cancer,single arm multi center phase ii study tislelizumab combined lenvatinib gemox conversion therapy potentially resectable locally advanced biliary tract zsab transgolp primary analysis jats p jats p jats p background previously reported gemox combined lenvatinib pd antibody golp regimen showed promising efficacy first line treatment advanced intrahepatic cholangiocarcinoma icca indicating golp regimen may ideal conversion therapy patients pts potentially resectable advanced biliary tract btc phase ii trial explored efficacy safety golp conversion therapy potentially resectable locally advanced btc methods patients potentially resectable locally advanced btc enrolled received tislelizumab mg q w lenvatinib mg qd gemox chemotherapy
98,Liver_Cancer,inflammation primary metastatic tumorigenesis influence alcohol high fat diets plays outsized role oncology tumors one frequently found tumors patients arise either primary metastatic disease hepatocellular carcinoma hcc prevalent form primary th common type overall expected become rd leading cause mortality us year also common site distant metastasis solid tumors instance colorectal crc metastasizes two thirds cases crc metastasis leading cause mortality patients interplay inflammation unmistakably evident nearly every case hcc diagnosed chronic disease cld cirrhosis background consumption western style high fat diet major risk factor development non alcoholic fatty disease nafld non alcoholic steatohepatitis nash becoming
99,Liver_Cancer,objective response predicts survival advanced hepatocellular carcinoma treated systemic therapies abstracttext label purpose increased number sequential treatments used advanced hepatocellular carcinoma hcc need surrogate endpoints overall survival os analyze whether objective response independent predictor surrogate endpoint os abstracttext abstracttext label patients methods systematic review randomized clinical trials rct advanced hcc published conducted explore os surrogacy response evaluation criteria solid tumors recist modified recist mrecist parallel rcts exploring impact os time dependent multivariate analysis integrated meta analysis abstracttext abstracttext label results rcts identified advanced hcc analyzed studies including patients reported os either recist n mrecist n n
100,Liver_Cancer,cyp b promotes colorectal metastasis enhancing growth metastatic cells via fatty acids dependent manner abstracttext label background nlmcategory unassigned metastasis lm accounts colorectal crc related deaths however metastatic crc cells gain ability survive grow remains largely unknown abstracttext abstracttext label methods nlmcategory unassigned first screened differentially expressed genes degs lm paired primary tumors pts gene expression omnibus geo database identified cytochrome p b cyp b common differential gene verified messenger rna mrna protein expression level clinical specimens constructing stable regulated cyp b versions hct rko crc cells stable regulated cyp b versions sw ht crc cells
101,Liver_Cancer,ksr complex serves biomarker potential therapeutic target sorafenib resistant hepatocellular carcinoma abstracttext label background nlmcategory background kinase suppressor ras ksr regulator mapk signaling overactivated hepatocellular carcinoma hcc sought determine role ksr hcc pathogenesis abstracttext abstracttext label methods nlmcategory methods tested level ksr hcc tissues cell lines tissue microarray qpcr western blotting functionally determined effects ksr proliferation migration invasion hcc cells colony formation assays scratch assays transwell migration assays xenograft tumor models co immunoprecipitation co ip experiments used assess interaction phospho serine binding protein ksr effects interaction growth proliferation human hcc cells tested co overexpression knockdown experiments
102,Liver_Cancer,immunotherapeutic response score predict prognosis unresectable hepatocellular carcinoma immune checkpoint inhibitors based conversion treatment jats p jats bold e jats bold jats p jats p jats bold background jats bold immune checkpoint inhibitor ici based conversion therapy increasingly utilized patients initially unresectable hepatocellular carcinoma hcc however immune related pathologic response irpr features post nat hcc resection specimens clinical significance remain poorly understood jats bold methods jats bold study included hcc patients received icis based conversion therapy followed curative resection irpr features clinical significance explored immunotherapeutic response score itrs developed including irpr features significant showing trend p
103,Liver_Cancer,transcatheter arterial embolization salvaged alpps novel alpps procedure especially patients hepatocellular carcinoma severe fibrosis cirrhosis abstracttext label background nlmcategory unassigned associating partition portal vein ligation staged hepatectomy alpps hepatocellular carcinoma hcc fibrosis cirrhosis often associated limited growth future remnant flr introduced new procedure named transcatheter arterial embolization salvaged alpps tae salvaged alpps shown especially suitable hcc patients cirrhosis fibrosis failed adequately respond conventional alpps short term efficacy safety tae salvaged alpps patients hcc fibrosis cirrhosis studied abstracttext abstracttext label methods nlmcategory unassigned consecutive hcc patients underwent tae salvaged alpps hospital november june retrospectively studied new alpps
104,Liver_Cancer,interleukin promotes progression hepatocellular carcinoma recruiting neutrophils abstracttext label background nlmcategory background growing number therapeutic strategies hepatocellular carcinoma hcc emerged however efficacy remains limited study investigated mechanism interleukin il progression hcc potential application hcc treatment abstracttext abstracttext label methods nlmcategory methods expression il gp il r ccl etc hcc tissues detected immunohistochemistry ihc expression il hcc cell lines detected fluorescence assay kaplan meier survival analysis il receptor relation overall survival os recurrence free survival rfs patients hcc mouse subcutaneous tumor models study effects il hcc growth immune cells western blot used detect expression il ccl fgf
105,Liver_Cancer,lncrna loxl promotes cell proliferation migration regulating mir p nfib axis becoming one lethal malignancies due high incidence mortality accumulating studies indicated long non coding rnas lncrnas critical regulators tumorigenesis development various types including lncrna loxl antisense rna loxl identified oncogene types human however role remains obscure reverse transcription quantitative pcr used measure loxl expression tissues cells western blot mtt colony formation glucose uptake wound healing assays used explore biological function loxl cells bioinformatics analysis rna pull luciferase reporter assays used explore molecular mechanism loxl cells statistical analysis used compare experimental results different groups present study
106,Liver_Cancer,world epidemiology incidence mortality risk factors objective sixth common second leading cause death around world significantly observable among male highest incidence age group years aim study investigate incidence mortality risk factors world materials methods review study performed published english studies searching databases pubmed scopus web science end strategy search includes key words hepatocellular carcinoma hcc epidemiology incidence mortality risk factors world reviewed studies incidence mortality risk factors results generally common east asia highest incidence rate mongolia standard incidence per people males females highest mortality rates occurred observed east asian countries standardized mortality rate per people males
107,Liver_Cancer,donafenib combined anti pd antibody transarterial chemoembolization tace first line l treatment unresectable advanced hepatocellular carcinoma hcc jats p e jats p jats p background targeted drugs immune checkpoint inhibitors tace important non surgical approaches treat hcc triple combination three investigation prospective study conducted assess efficacy safety donafenib combined anti pd antibody tace first line treatment unresectable advanced hcc methods patients pts histologically clinically confirmed hcc prior systemic therapy least one measurable lesion per mrecist child pugh score ecog ps score enrolled received donafenib mg twice daily anti pd antibody q w demand conventional tace ct
108,Liver_Cancer,decade studies metastasis hepatocellular carcinoma metastasis remains one major challenges hepatocellular carcinoma hcc finally conquered paper summarized decade studies hcc metastasis institute fudan university established stepwise metastatic human hcc model system included metastatic hcc model nude mice lci hcc cell line high metastatic potential mhcc relatively low metastatic potential cell clone mhcc l several stepwise high metastatic potential cell clones mhcc h hcclm hcclm parent mhcc cell endeavors made searching human hcc metastasis related chromosomes proteins genes monogene based studies revealed hcc invasion metastasis similar solid tumors biological characteristics small hcc slightly better large hcc using
109,Liver_Cancer,serum epidermal growth factor like domain serves novel diagnostic marker early hepatocellular carcinoma jats title abstract jats title jats p jats bold background jats bold epidermal growth factor like domain egfl recently identified secreted protein significantly increased patients hcc previous studies however efficacy diagnosis early hcc remains unknown study evaluate efficacy serum egfl early hcc diagnosis compare alpha fetoprotein afp jats bold methods jats bold serum egfl levels testing cohort participants validation cohort participants measured sandwich enzyme linked immunoassay elisa efficacies egfl afp diagnosing early hcc estimated receiver operating characteristic roc jats bold results jats bold
110,Liver_Cancer,comparative study syndrome characteristics h tumor mice different strains objective observe compare traditional chinese medicine syndrome characteristics difference h tumor mice different strains methods thirty mice km balb c icr c respectively randomly divided control group n group n mice group inoculated h cells establish tumor bearing model survival rate mice different strains observed syndromes mice detected four diagnostic method workstation results solid tumour formed mice four strains survival rate significant difference among four strains mice early phase significant difference middle advanced phase survival rate balb c mice lowest icr km mice followed c mice highest
111,Liver_Cancer,therapeutic potential flavonoids modulating mitochondrial activity insights hepg cell studies jats p background leading cause mortality globally affects various organs including contributing approximately deaths malaysia increasingly prevalent hepg cell line derived human hepatoma widely used studying drug induced injuries flavonoids group polyphenolic compounds found plants gained attention diverse pharmacological activities including potential mitigate carcinogenesis tumorigenesis methods review synthesizes findings studies investigating impact flavonoids focusing hepg cell line explore flavonoid subtypes therapeutic roles including antioxidant anti inflammatory anti angiogenic cytotoxic properties research mitochondrial function cells flavonoids influence mitochondrial activity hepg cell line also assessed results flavonoids demonstrated
112,Liver_Cancer,lenvatinib induces immunogenic cell death triggers toll like receptor ligands hepatocellular carcinoma abstracttext label purpose nlmcategory unassigned immunogenic cell death icd cell death modality plays vital role anticancer therapy study investigated whether lenvatinib induces icd hepatocellular carcinoma affects cell behavior abstracttext abstracttext label patients methods nlmcategory unassigned hepatoma cells treated lenvatinib two weeks damage associated molecular patterns assessed using expression calreticulin high mobility group box atp secretion transcriptome sequencing performed investigate effects lenvatinib hepatocellular carcinoma additionally cu cpt tak used inhibit tlr tlr expressions respectively flow cytometry used assess pd l expression kaplan meier cox regression
113,Liver_Cancer,abstract tnfaip increases drug resistance steatosis inducing autophagy tumor necrosis factor inducible protein tnfaip tnf inducible anti apoptotic protein facilitates tumor growth progression several molecular mechanisms tnfaip modulates progression remain elusive present study investigated role tnfaip cell growth drug resistance survival cell steatosis tissue microarray data patients demonstrated increased expression tnfaip protein development different stages compared normal tissues test correlation tnfaip expression progression transiently stably expressed tnfaip protein cell lines expression tnfaip cells hepg sk hep increased cell growth survival drug resistance anti drugs sorafenib regorafenib inhibition apoptosis addition tnfaip knockdown sensitized tumor cell lines sorafenib
114,Liver_Cancer,integration inflammation immune factors build prognostic model predictive prognosis minimal residual disease hepatocellular carcinoma abstracttext label background nlmcategory unassigned tumor recurrence hepatectomy high hepatocellular carcinoma hcc minimal residual disease mrd could underlying mechanism predictive model recurrence presence mrd needed abstracttext abstracttext label methods nlmcategory unassigned common inflammation immune factors reviewed selected construct novel models model consisting preoperative aspartate aminotransferase c reactive protein lymphocyte count named aclr selected evaluated clinical significance abstracttext abstracttext label results nlmcategory unassigned among nine novel inflammation immune models aclr showed highest accuracy overall survival os time recurrence ttr optimal cutoff value patients
115,Liver_Cancer,immune gene expression signature associated development human hepatocellular carcinoma identifies mice respond chemopreventive agents background aims cirrhosis chronic inflammation precede development hepatocellular carcinoma hcc approximately cases investigated immune related gene expression patterns tissues surrounding early stage hccs chemopreventive agents might alter patterns prevent tumorigenesis methods analyzed gene expression profiles nontumor tissues patients early stage hcc training set n validation set n tissue patients cirrhosis without hcc n controls identify changes expression genes regulate immune response could contribute hepatocarcinogenesis defined genes markers deregulated immune response called immune mediated field icf analyzed expression data tissues patients cirrhosis without
116,Liver_Cancer,circnfib inhibits tumor growth metastasis suppressing mek erk signaling intrahepatic cholangiocarcinoma abstracttext label background considerable evidence shows circular rnas circrnas play important role tumor development however function intrahepatic cholangiocarcinoma icc metastasis underlying mechanisms incompletely understood abstracttext abstracttext label methods circnfib hsa circ termed cnfib hereafter identified human icc tissues circrnas sequencing biological role cnfib determined vitro vivo gain loss functional experiments fluorescence situ hybridization fish rna immunoprecipitation rip rna pull assays conducted analyze interaction cnfib dual specificity mitogen activated protein kinase kinase mek duolink situ proximity ligation assay pla coimmunoprecipitation co ip assay used investigate effects
117,Liver_Cancer,epigenome wide development validation prognostic methylation score intrahepatic cholangiocarcinoma based machine learning strategies abstracttext label background nlmcategory unassigned clinical parameter based nomograms staging systems provide limited information prediction survival intrahepatic cholangiocarcinoma icc patients study developed methylation signature precisely predicts overall survival os surgery abstracttext abstracttext label methods nlmcategory unassigned epigenome wide study dna methylation based whole genome bisulfite sequencing wgbs conducted two independent cohorts discovery cohort n validation cohort n three hepatobiliary centers china referring differentially methylated regions dmrs proposed concept prognostically methylated regions pmrs composed consecutive prognostically methylated cpgs pmcs using machine learning strategies random
118,Liver_Cancer,long noncoding rna tlnc promotes growth metastasis via inhibition p signaling abstracttext label background long non coding rnas lncrnas demonstrated play vital roles development progression however biological roles function mechanisms remain largely unknown abstracttext abstracttext label methods rna seq performed clinical hepatoma tissues paired adjacent normal tissues identify differentially expressed lncrnas qpcr utilized examine expression levels lncrnas studied function tlnc cell growth metastasis hepatoma cell mouse models rna seq rna pull coupled mass spectrometry rna immunoprecipitation dual luciferase reporter assay surface plasmon resonance analysis used analyze functional mechanism tlnc abstracttext abstracttext label results based intersection rna
119,Liver_Cancer,novel risk prediction model patients combined hepatocellular cholangiocarcinoma backgrounds regarding difficulty chc diagnosis potential adverse outcomes misuse clinical therapies increasing number patients undergone transplantation transcatheter arterial chemoembolization tace treatments objective construct convenient reliable risk prediction model identifying high risk individuals combined hepatocellular cholangiocarcinoma chc methods patients underwent surgical resection zhongshan hospital enrolled study epidemiological clinical characteristics patients collected time tumor diagnosis variables p univariate analyses evaluated using backward stepwise method receiver operating characteristic roc curve used assess model discrimination calibration performed using hosmer lemeshow test calibration curve internal validation performed using bootstrapping approach results among entire
120,Liver_Cancer,malbi child pugh based nomogram predicting post hepatectomy failure grade b c patients huge hepatocellular carcinoma multi institutional study jats title abstract jats title jats p objective post hepatectomy failure phlf severe complication patients hepatocellular carcinoma hcc underwent hepatectomy study aims develop nomogram severe phlf patients huge hcc diameter cm methods retrospectively collected clinical information patients underwent hepatectomy huge hcc two medical centers univariate multivariate analysis used screen independent factors phlf grade b c visualized nomogram results hcc patients included training cohort internal validation cohort external validation cohort probabilities phlf grade b c respectively pre operative
121,Liver_Cancer,expression analysis mir serum tissue process development rats objective explore whether microrna mir could used novel biomarker using rat model system methods diethylnirtosamine abdominal injection applied induce f rat strain n ten unmodeled rats served controls addition human subjects normal healthy n cirrhosis n n enrolled study blood samples rats patients rats livers collected analysis real time quantitative pcr enzyme linked immunosorbent assay used respectively measure expressions serum mir alpha fetoprotein afp rat human subjects situ hybridization used detect mir expression rats livers results comparison normal rats modeled rats showed latter significantly lower expression mir p
122,Liver_Cancer,tumor associated macrophages derived exosomes facilitate hepatocellular carcinoma malignance transferring lncmmpa tumor cells activating glycolysis pathway abstracttext label background nlmcategory background tumor associated macrophages tams form large part tumor microenvironment normally regulated metabolic reprogramming however potential mechanisms immune metabolism interaction hepatocellular carcinoma hcc cells tams remain unclear abstracttext abstracttext label methods nlmcategory methods candidate long non coding rnas lncrnas screened smart seq based scrna seq method validated qpcr immunostaining analysis done examine levels markers tams glycolysis exosomes primary tams human hcc tissues isolated centrifugation internalization lncrnas confirmed immunofluorescence underlying mechanism tams derived exosomal lncrna hcc confirmed
123,Liver_Cancer,lenvatinib plus anti pd therapy represents feasible conversion resection strategy patients initially unresectable hepatocellular carcinoma retrospective study abstracttext label purpose nlmcategory unassigned aimed investigate feasibility lenvatinib plus anti pd therapy conversion therapy initially unresectable hepatocellular carcinoma hcc abstracttext abstracttext label methods nlmcategory unassigned patients initially unresectable hcc received combined lenvatinib anti pd antibody may jan zhongshan hospital retrospectively analyzed tumor response resectability assessed imaging every two months according recist version modified recist mrecist criteria abstracttext abstracttext label results nlmcategory unassigned total patients enrolled received conversion surgery within range days initiation lenvatinib plus anti pd therapy baseline
124,Liver_Cancer,serial circulating tumor dna profiling predicts tumor recurrence transplantation abstracttext label background nlmcategory background minimal residual disease mrd proposed responsible tumor recurrence role circulating tumor dna ctdna detect mrd monitor recurrence predict prognosis patients undergoing transplantation lt remains unrevealed abstracttext abstracttext label methods nlmcategory methods serial blood samples collected profile ctdna mutational changes baseline ctdna mutational profiles compared matched tumor tissues correlations ctdna status recurrence rate rr recurrence free survival rfs analyzed respectively dynamic change ctdna monitored predict tumor recurrence abstracttext abstracttext label results nlmcategory results baseline mutational profiles ctdna highly concordant tumor tissues median range
125,Liver_Cancer,elimination tumor suppressor proteins carcinogenesis one lethal quiescent expresses tumor suppressor proteins including rb p ccaat enhancer binding protein c ebp hepatocyte nuclear factor hnf p well protected development however negative control proliferation factors tumor suppressor genes eliminated studies regeneration surgery injury provided fundamental mechanisms neutralizes tumor suppressor proteins time regeneration however studies animal models human samples showed several additional pathways neutralization one addi tional pathways includes activation small subunit proteasome gankyrin gankyrin dramatically increased human hepatocellular carcinoma hcc animal models car cinogenesis activated gankyrin triggers degradation main tumor suppressor proteins development using slightly different mechanisms
126,Liver_Cancer,enhancing hepatocellular carcinoma management prognostic value integrated ccl ccr cd hhla expression analysis abstracttext label purpose nlmcategory objective hepatocellular carcinoma hcc critical global health concern existing treatments benefiting minority patients recent findings implicate chemokine ligand ccl receptor ccr pivotal players tumor microenvironment tme various investigation aims delineate roles ccl ccr modulating tumor immune landscape assessing potential therapeutic interventions prognostic markers hcc abstracttext abstracttext label methods nlmcategory methods hcc patients post radical surgery zhongshan hospital fudan university retrospectively examined individuals stratified training cohort n validation cohort n immunohistochemical analysis hcc tissue arrays expressions ccl ccr cd cd
127,Liver_Cancer,clinical significance serum il il bp patients benign malignant primary tumor objective study relationship serum il il bp occurrence development primary benign tumor cirrhosis investigate role serum il il bp detection diagnosis primary methods serum levels il il bp patients primary patients various benign tumor patients cirrhosis determined elisa assay levels afp patients primary examined relationship among levels serum il bp afp patients primary explored results sil level patients primary significantly lower control groups patients various benign tumor lc sil bp patients primary significantly higher control groups patients various benign tumour cirrhosis p il il bp
128,Liver_Cancer,incidence rate saudi arabia observational descriptive epidemiological analysis data saudi registry objective study describes epidemiological pattern regions saudi arabia explores frequency cases diagnosed age specific incidence rate air crude incidence rate cir age standardised incidence rate asir stratified age group year diagnosis region methods retrospective descriptive epidemiological analysis cases documented saudi registry scr performed data analysed using descriptive statistics test kruskal wallis sex ratio statistical package social sciences version spss results total cases registered scr january december highest overall asir among saudi males observed regions riyadh najran tabuk per males respectively furthermore riyadh eastern region tabuk
129,Liver_Cancer,multi model analysis gallbladder reveals role oxldl absorbing neutrophils promoting invasion abstracttext label background nlmcategory background gallbladder gbc common lethal malignancy biliary tract lacks effective therapy many gbc cases infiltration adjacent organs distant metastasis happened long diagnosis especially direct invasion common unfavorable way spreading abstracttext abstracttext label methods nlmcategory methods single cell rna sequencing scrna seq spatial transcriptomics st proteomics multiplexed immunohistochemistry mihc performed gbc across multiple tumor stages characterize tumor microenvironment tme focusing specifically preferential enrichment neutrophils gbc invasion gbc li abstracttext abstracttext label results nlmcategory results multi model analysis reveals immunosuppressive tme gbc li
130,Liver_Cancer,capecitabine temozolomide metastatic intermediate high grade pancreatic neuroendocrine neoplasm single center experience abstracttext label background aims combination capecitabine temozolomide captem one treatment options metastatic pancreatic neuroendocrine neoplasms pnens study aims evaluate efficacy captem patients metastatic intermediate high grade pancreatic neuroendocrine tumor pnet carcinoma pnec abstracttext abstracttext label methods study conducted retrospectively single center patients treated intermediate high grade tumor mg capecitabine twice daily day mg temozolomide daily day repeating twice cycle days primary outcomes durations overall survival os progression free survival pfs secondary outcomes consisted objective response rate disease control rate abstracttext abstracttext label results total
131,Liver_Cancer,expression clinical significance extracellular matrix protein primary objective detect expression extracellular matrix protein ecm primary tissues explore clinical significance metastasis methods sixty cases primary tissues adjacent tissues patients admitted affiliated provincial hospital anhui medical university june december collected nine cases normal tissues collected patients trauma control expression ecm relationship ecm clinicopathological features detected analyzed using immunohistochemistry western blot data analyzed using chi square test fisher exact test test results ecm mainly expressed cytoplasm cells positive expression rate ecm tissues significantly higher adjacent tissues normal tissues x p expression ecm correlated metastasis tnm stages x p sex
132,Liver_Cancer,prospective cohort studies association family history risk uncertainty remains relationship family history risk prospective cohort studies general population thus examined association participants shanghai women men health studies family history categorized dichotomous proportional score approaches hazard ratios hrs confidence intervals cis derived using cox proportional hazards models adjustment potential confounders meta analysis observational studies december risk relation family history also performed study specific risk estimates combined using fixed random effects models depending whether significant heterogeneity detected shanghai women men health studies cases identified follow family history associated risk using binary indicator hr ci proportional score high risk
133,Liver_Cancer,abstract po identification igf genomic driver actionable therapeutic target hepatoblastoma jats title abstract jats title jats p background aims management hepatoblastoma hb frequent pediatric based surgical resection perioperative chemotherapy regimens commonly cisplatin aimed identify actionable targets hb assess efficacy molecular therapies preclinical models hb methods paired tumor adjacent tissues resected hbs validation set hbs analyzed transcriptomic genomic epigenomic level using rnaseq snp methylation arrays respectively main targetable driver hb identified gene co expression network analysis gcn overexpression confirmed qrt pcr anti tumor effect driver inhibition molecular therapies alone combination cisplatin assessed cell lines patient derived hb
134,Liver_Cancer,data geospatial immune heterogeneity reflects diverse tumor immune interactions intrahepatic cholangiocarcinoma jats p lt div gt abstract lt p gt intrahepatic cholangiocarcinoma icca exhibits extensive intratumoral heterogeneity extremely high mortality rate performed whole exome sequencing rna sequencing cell receptor tcr sequencing multiplexed immunofluorescence tumor regions patients icca half icca displayed intratumoral heterogeneity immune infiltration icca classified sparsely heterogeneously highly infiltrated subgroups distinct immunogenomic characteristics sparsely infiltrated tumors displayed active copy number loss clonal neoantigens heterogeneous immune infiltration played important role subclonal evolution across tumor subregions highly infiltrated tumors characterized extensive immune activation similar tcr repertoire across
135,Liver_Cancer,association increment serum vegf level prognosis transcatheter arterial chemoembolization hepatocellular carcinoma patients prospectively investigated association change serum vascular endothelial growth factor vegf level transcatheter arterial chemoembolization tace hepatocellular carcinoma hcc patient prognosis study involved patients unresectable hcc treated national center korea july december serum samples collected patient tace days month tace serum vegf concentrations measured using enzyme linked immunosorbent assay elisa log e vegf platelets increased transiently days tace declined thereafter frequency previous tace correlate log e vegf platelets study found log e vegf platelets days tace log e vegf platelets baseline strongly correlated vascular nodal
136,Liver_Cancer,classification long non coding rnas early late stage non coding rna profiles using machine learning approach long non coding rnas lncrnas rna sequences greater nucleotides length play crucial role regulating gene expression biological processes associated development progression major cause related mortality worldwide notably thailand although machine learning extensively used analyzing rna sequencing data advanced knowledge identification potential lncrna biomarkers particularly focusing lncrnas molecular biomarkers remains comparatively limited study objective identify candidate lncrnas employed expression data set lncrnas patients comprised lncrnas sourced cancerliver database various feature selection methods machine learning approaches used identify candidate lncrnas results showed
137,Liver_Cancer,f fdg pet ct predicts prognosis patients hepatocellular carcinoma undergoing transplantation abstracttext label introduction nlmcategory unassigned addition radical resection transplantation ltx effective treatment hepatocellular carcinoma hcc however tumor recurrence limits efficacy ltx patients study investigated role sup sup f fludeoxyglucose sup sup f fdg positron emission tomography computed tomography pet ct predicting prognosis patients hcc ltx abstracttext abstracttext label methods nlmcategory unassigned total consecutive patients hcc underwent pre ltx pet ct divided derivation n temporal validation n cohorts evaluated pet ct values immunohistochemical ihc findings dna sequencing tumor tissues abstracttext abstracttext label results nlmcategory unassigned patients
138,Liver_Cancer,review chinese clinical guidelines management hepatocellular carcinoma updates insights significant improvements management hepatocellular carcinoma hcc past three years urged timely update clinical guidelines china brief amap score newly recommended effective risk stratification tool predict hcc occurrence especially non cirrhotic patients biomarker based surveillance including micro rna panel galad score advocated assist early diagnosis china cnlc staging system proposed guideline continues standard model staging modifications treatment allocations conversion therapies using multi modal high intensity strategies advocated facilitate subsequent resection patients technically unresectable cnlc stage ia ib iia hcc technically resectable iib iiia hcc super selective transcatheter arterial
139,Liver_Cancer,kras acting erk signaling stabilizes pd l via inhibiting autophagy pathway intrahepatic cholangiocarcinoma abstracttext label background nlmcategory background correlation pd l expression kras mutation previously reported solid tumors non small cell lung nsclc whether pd l modulated erk signaling downstream kras intrahepatic cholangiocarcinoma icca underlying molecular regulatory mechanism remain unclear abstracttext abstracttext label methods nlmcategory methods expression erk p erk pd l autophagy markers following kras knockdown ras raf mek erk signaling inhibitors treatment examined two human icca cell lines hucct rbe using western blotting immunofluorescence pharmacological autophagy inhibitors short interfering rna atg applied inhibit autophagy
140,Liver_Cancer,prognostic correlation heart rate variability body weight status patients title abstract title p background weight status play important role evolution prognosis patients however alterations autonomic nervous system ans caused may associated symptoms related weight change objective aim study identify influence weight status ans determine whether ans used index early detection prediction weight changes patients hrv methods conducted retrospective analysis clinical data newly diagnosed china authors conducted clinical ecg data special emphasis advances ecg bmi aspect results bmi kps lower group compared benign tumor patients healthy controls p patients likely history diabetes p hepatitis b virus infection
141,Liver_Cancer,wwox tuning oleic acid signaling orchestrates immunosuppressive macrophage polarization sensitizes hepatocellular carcinoma immunotherapy abstracttext label background nlmcategory background immune checkpoint inhibitors icis therapeutically effective hepatocellular carcinoma hcc individually selective study examined role specific common fragile sites cfss related gene hcc immunotherapy abstracttext abstracttext label methods nlmcategory methods analyzed hcc tissues using next generation sequencing flow cytometry via time flight technology humanized orthotopic hcc mouse model vitro co culture system untargeted metabolomics dna pulldown assay used examine function mechanism wwox tumor immune response abstracttext abstracttext label results nlmcategory results wwox upregulated cfs related gene hcc patients responsive
142,Liver_Cancer,distinct prognosis biliary tract according tumor location stage treatment population based study background biliary tract btc affects many distinct regions inconsistently identified epidemiological clinical studies study investigated treatment pattern prognosis btc according tumor location using national registry data methods korea central registry data patients btc retrospectively reviewed surveillance epidemiology end results seer stage first course treatment ft administered within four months diagnosis year relative survival rate yrs analyzed gallbladder gb intrahepatic bile duct ihbd extrahepatic bile duct ehbd ampulla vater aov results proportion localized regional l r stage highest aov followed ehbd gb ihbd significantly increased
143,Liver_Cancer,cd neutrophils drive extracellular matrix remodelling hgf alpha release alpps induced regeneration abstracttext label background nlmcategory background associating partition portal vein ligation staged hepatectomy alpps effectively induces rapid hypertrophy patients initially unresectable tumours yet immunological mechanisms remain unclear abstracttext abstracttext label objective nlmcategory objective aim elucidate immune alterations underlying mechanisms driving regeneration following alpps abstracttext abstracttext label design nlmcategory methods cohort study included single cell rna sequencing scrna seq spatial transcriptomics remnant tissues alpps patients neutrophil infiltration validated flow cytometry histological analyses world largest alpps clinical cohort mouse alpps models functional validation including neutrophil depletion matrix
144,Liver_Cancer,physician patient communication associated hepatocellular carcinoma screening chronic disease patients background patients chronic disease high risk developing factors associated screening awareness doctor patient communication regarding examined study four hundred sixty seven patients chronic disease tertiary care clinic participated phone survey regarding awareness screening doctor patient communication health behaviors medical records retrospectively reviewed data disease etiology dates imaging tests results seventy nine percent patients reported awareness screening reported talking doctor patients higher education abstinence alcohol cirrhosis likely aware screening p whites patients higher education cirrhosis likely talk doctor p p awareness screening similar colorectal screening lower breast
145,Liver_Cancer,investigating tumour suppressive role autophagy related genes formation predicted third leading cause related deaths uk hepatocellular carcinoma accounting driven chronic rounds inflammation resulting fibrosis cirrhosis ultimately autophagy intracellular recycling mechanism dual role preventing initiation also supporting growth progression established tumours autophagy prevents inflammation fibrosis tumorigenesis suppresses formation atypical ductular cells parenchyma process named ductular reaction ductular reaction repair mechanism develops following chronic injuries hepatocyte function severely impaired regenerate new hepatocyte restore function details specific role autophagy however origin role ductular reaction remain unclear autophagy deficient livers addition unclear autophagy modulated tumorigenesis report new genetically engineered mouse
146,Liver_Cancer,hepatectomy conversion therapy using tyrosine kinase inhibitors plus anti pd antibody therapy patients unresectable hepatocellular carcinoma abstracttext label background nlmcategory background combined treatment tyrosine kinase inhibitors tki plus anti pd antibodies showed high anti tumor efficacy made conversion resection possible patients unresectable hepatocellular carcinoma hcc however long term survival reported abstracttext abstracttext label methods nlmcategory methods cohort consecutive patients received combined tki anti pd antibodies first line treatment initially unresectable hcc authors hospital august september eligible study patients responding systemic therapy met criteria hepatectomy underwent resection curative intention study also investigated association clinical factors successful conversion
147,Liver_Cancer,sintilimab plus bevacizumab followed resection intermediate stage hepatocellular carcinoma phase ib clinical trial biomarker analysis abstracttext label objective nlmcategory unassigned phase ib trial aimed assess safety efficacy sintilimab plus bevacizumab sintilimab bev followed resection patients potentially resectable intermediate stage hepatocellular carcinoma hcc explore clinical implications circulating tumour dna ctdna cell receptor tcr repertoire abstracttext abstracttext label methods analysis nlmcategory unassigned eligible patients intermediate stage hcc received sintilimab bev treatment patients partial response stable disease least two consecutive evaluations technically resectable received hepatectomy postoperatively patients continued receive sintilimab bev tumour recurrence intolerable toxicities months primary endpoints treatment
148,Liver_Cancer,perioperative oncologic outcomes laparoscopic versus open resection combined hepatocellular cholangiocarcinoma propensity score matching analysis abstracttext label background laparoscopic resection llr established safe minimally invasive technique deemed feasible treating hepatocellular carcinoma hcc intrahepatic cholangiocarcinoma icc however role llr treating combined hepatocellular cholangiocarcinoma chcc cc patients rarely reported study aimed assess efficacy llr compared open resection olr procedure patients chcc cc abstracttext abstracttext label methods total chcc cc patients underwent hepatic resection llr olr patients january december zhongshan hospital fudan university enrolled underwent propensity score matching psm analysis llr olr groups compare perioperative oncologic outcomes overall survival os
149,Liver_Cancer,repolarization immunosuppressive macrophages targeting slamf regulated ccl signaling sensitizes hepatocellular carcinoma immunotherapy abstracttext immune checkpoint inhibitors limited efficacy hepatocellular carcinoma hcc macrophages abundant immune cells hcc suggesting better understanding intrinsic processes tumor cells regulate macrophages could help identify strategies improve response immunotherapy signaling lymphocytic activation molecule slam family members regulate various immune functions investigated role specific slam receptors immunobiology hcc comparison transcriptomic landscapes immunotherapy responsive nonresponsive patients advanced hcc identified slamf upregulation immunotherapy responsive hcc patients hcc responded immunotherapy also displayed higher serum levels slamf loss slamf specific knockout mice led increased hepatocarcinogenesis metastasis elevated immunosuppressive
150,Liver_Cancer,matrix stiffness promotes invasion metastasis hepatocellular carcinoma via new mechanoresponsive scd hmmr pathway hepatocellular carcinoma hcc almost exclusively develops context fibrosis cirrhosis characterized increased matrix stiffness matrix stiffness promotes hcc invasion metastasis via upregulation stearoyl coa desaturase scd however downstream effector scd dependent mechanoresponsive pathway remains unclear hcc cells grown mechanically tunable polyacrylamide gels matrigel supplemented culture media subjected vitro invasion assay key molecule responded matrix stiffness identified underlying mechanism molecule participated vitro matrix stiffness induced invasion vivo metastasis explored high matrix stiffness caused increase hyaluronan mediated motility receptor hmmr expression enhanced invasion hcc cells vitro
151,Liver_Cancer,novel microenvironment based classification intrahepatic cholangiocarcinoma therapeutic implications abstracttext label objective diversity tumour microenvironment tme intrahepatic cholangiocarcinoma icca comprehensively assessed aimed generate novel molecular icca classifier incorporates elements stroma tumour immune microenvironment stim classification abstracttext abstracttext label design applied virtual deconvolution transcriptomic data iccas enabling us devise novel classification selecting relevant tme components murine models generated hydrodynamic tail vein injection compared human disease abstracttext abstracttext label results icca composed five robust stim classes encompassing inflamed non inflamed profiles inflamed classes named immune classical inflammatory stroma differ oncogenic pathways extent desmoplasia inflammatory stroma showing cell exhaustion abundant
152,Liver_Cancer,macrophage cell interaction three dimension model jats p hepatocellular carcinoma hcc one leading causes related mortality progression significantly influenced immune cells infiltrate tumors interaction cells tumor microenvironment tme circulating monocytes recruited tumor site tme differentiated tumor associated macrophages tams roughly divided pro inflammatory macrophages pro tumoral macrophages order study interaction macrophages cells vitro effective model closely mimicks crosstalk necessary study aimed fabricate three dimension model investigate cells induced regulatory mechanism tams impact biased notch signaling pathway macrophages cells developed spheroids combining primary human cd monocytes human cell lines hepg plc prf using ultra low attachment plate
153,Liver_Cancer,contributory factors diagnosis treatment high mortality secondary hepatitis b hepatitis c secondary alcohol hepatocellular carcinoma hcc common form highest rates china sub saharan africa approximately primary hcc also named hepatoma cholangiocarcinoma form within bile duct fluke infection increases risk cholangiocarcinoma thailand tumor blood vessels angiosarcoma produced muscles leiomyosarcoma many due metastasis contributory factors includes viral infection either hepatitis c hcv hepatitis b hbv viruses cause hcc massive inflammation fibrosis eventual cirrhosis within aflatoxin exposure lead development hcc high grade dysplastic nodules precancerous lesions beckwith weidemann syndrome associated hepatoblastoma children associated abdominal mass abdominal pain emesis anemia
154,Liver_Cancer,whole exome sequencing based mutational profiling hepatocellular adenoma malignant transformation hepatocellular carcinoma hepatocellular adenoma hca represents rare benign hepatic neoplasm potential malignant transformation hepatocellular carcinoma hcc yet underlying mechanism remains elusive study investigated genomic landscape process identify therapeutic strategies blocking malignant transformation using micro detection techniques obtained specimens adenoma cancerous neoplasm adjacent normal three patients undergoing hepatic resection surgery whole exome sequencing wes performed genomic interactions hca hcc components within tumour evaluated using somatic variant calling copy number variation cnv analysis clonality evaluation mutational signature analysis results revealed genomic heterogeneity among patient cases yet within sample
155,Liver_Cancer,abstract regeneration radiation therapy clinical observations new rat model jats title abstract jats title jats p background purpose radiation induced damage dose limiting complication radiotherapy tumors focused mainly prevention treatment largely ignored molecular mechanisms underlying regenerative capacity irradiation whether regeneration compensates radiation induced damage great clinical significance study aims observe clinical regeneration potential molecular mechanism rat models irradiation jats p jats p methods stimulate regeneration response delineated protection area patient normal protect excessive irradiation designed rat model large single fractions gy gy radiation delivered total volume investigate regeneration irradiation used proteomics analysis western blotting assays investigate
156,Liver_Cancer,abstract whole genome virome immuno genome indicate genomic feature associated virus infection inflammation jats title abstract jats title jats p prevalent worldwide mainly associated virus infection chronic inflammation underlying molecular mechanism quite heterogeneous performed virome immuno genomic analyses addition whole genome landscape somatic alterations transcriptome whole genome analysis elucidated point mutations non coding regions structural variations virus integrations hbv aav addition coding mutations discovered novel recurrently mutated coding non coding regions neat malat lincrnas promoters ctcf binding sites novel regulatory regions known genes cdkn apc tert novel genes ash l ncor macrod recurrently affected svs virome
157,Liver_Cancer,burden trends primary caused specific etiologies global regional national age sex level results global burden disease study background one leading causes related deaths worldwide primary causes include hepatitis b virus hbv hepatitis c virus hcv alcohol consumption nonalcoholic fatty disease factors aims objective study evaluate global sex age region country etiology related burden well trends caused different etiologies methods causes including global regional national incidence mortality etiology collected global burden disease study time dependent change trends burden evaluated annual percentage change results global incidence mortality increasing newly diagnosed cases deaths twice numbers recorded hbv hcv major
158,Liver_Cancer,influence f fluorodeoxyglucose positron emission tomography computed tomography n staging subsequent clinical management intrahepatic cholangiocarcinoma abstracttext label background nlmcategory unassigned intrahepatic cholangiocarcinoma icc highly metastatic sup sup f fluorodeoxyglucose positron emission tomography computed tomography sup sup f fdg pet ct enables sensitive tumor metastasis detection aim evaluate influence pre treatment pet ct n staging subsequent clinical management icc patients abstracttext abstracttext label methods nlmcategory unassigned august august consecutive icc patients without prior anti tumor treatments malignancies enrolled diagnostic performance pet ct n staging compared conventional imaging preoperative staging accuracy treatment allocation pet ct retrospectively calculated survival
159,Liver_Cancer,clinical study effect il il postoperative colorectal metastasis objective observe effect il il postoperative colorectal metastasis methods samples peripheral blood respectively collected form healthy adults patients preoperative postoperative coloreatal patient postoperative coloreatal metastasis since jan jun level il il detected elisa method lymphocyte subgroups detected facs calibur flow cytometry results statistically analyzed results level il postoperative coloreatal metastasis significantly higher healthy adult postoperative coloreatal p level il postoperative coloreatal significantly lower preoperative coloreatal p level il preoperative post operative coloreatal postoperative coloreatal metastasis significantly lower healthy adults p levelof il preoperative postoperative coloreatal well postoperative coloreatal
160,Liver_Cancer,zsab top phase trial tislelizumab tis ociperlimab oci combined gemcitabine cisplatin gemcis first line treatment advanced biliary tract btc jats p jats p jats p background gemcis long standard care advanced btc however prognosis remains poor combinations immunotherapy gemcis explored btc study aimed evaluate efficacy safety tis anti pd antibody oci tigit inhibitor combined gemcis first line treatment advanced btc herein primary analysis results study reported methods open label single arm multicenter phase study systematic treatment na pts unresectable advanced btc received tis mg day q w oci mg day q w gemcis gem mg jats
161,Liver_Cancer,abstract integrative molecular classification extrahepatic cholangiocarcinoma jats title abstract jats title jats p background aims cholangiocarcinoma cca second common primary hepatic malignancy based anatomical location cca divided intrahepatic icca extrahepatic ecca differences etiology pathogenesis clinical management studies focused molecular profiling ecca single entity even though accounts prevalent subtype thus integrative genomic analysis ecca would provide critical understanding biological traits tumor jats p jats p methods ffpe primary ecca treated resection collected seven international centers median survival cohort mo whole gene expression profiles submitted unsupervised clustering nmf consensus clusters characterized gene set enrichment analysis ingenuity pathway analysis
162,Liver_Cancer,abstract roles primary bile acid receptor fxr repair tumorigenesis proceedings aacr rd annual meeting mar apr chicago il bile acids promote processing dietary fat regulate glucose homeostasis receptor fxr study demonstrate bile acid fxr signaling also plays role tissue homeostasis repair well hepatocarcinogenesis either decreased bile acid level loss fxr leads impaired regeneration carbon tetrachloride induced injury partial hepatectomy indicates fxr essential protector regulating cell proliferation death indeed fxr mice spontaneously develop aged due chronic injury deregulated repair addition fxr expression regulated human tumors compared non tumor regions hepatocarcinogenesis fxr mice recapitulate process human initiation progression
163,Liver_Cancer,novel mrna signature related immunity predict survival immunotherapy response hepatocellular carcinoma abstracttext label background aims nlmcategory unassigned hepatocellular carcinoma hcc common primary incidence mortality rates increasing given limited treatments hcc promising application immunotherapy aimed identify immune related prognostic signature predict overall survival os rates immunotherapy response hcc abstracttext abstracttext label methods nlmcategory unassigned initial signature development conducted using training dataset genome atlas followed independent internal external validations resource gene expression omnibus signature based nomogram generated using multivariate cox regression analysis associations signature score tumor immune phenotype response immunotherapy analyzed using single sample gene set enrichment analysis
164,Liver_Cancer,alcoholic disease relation incidence mortality findings large matched cohort study south korea abstracttext label aim estimate risk incidence mortality among patients alcoholic disease south korea abstracttext abstracttext label methods matched cohort study conducted including men alcoholic disease cases controls women alcoholic disease cases controls matched sex age smoking alcohol consumption body mass index ratio risk incidence mortality alcoholic disease group assessed using cox proportional hazards regression models abstracttext abstracttext label results men women alcoholic disease elevated risk incidence mortality comparison control group men alcoholic disease associated significantly higher risk development types including lip oral cavity pharynx
165,Liver_Cancer,abstract ia postpartum breast involution informs breast metastasis jats title abstract jats title jats p young women breast disproportionally higher rates metastasis effective treatment strategies lacking lab focused investigating normal reproductive changes tissue biology interface breast metastasis young patients studies identify weaning induced involution breast tissue remodeling process similar wound healing promotes metastasis rodent models relevance women suggested fact breast diagnosis within years childbirth strong independent risk factor metastasis studies find young onset breast diagnosed within high risk postpartum window subset common young onset breast referred postpartum breast ppbc find ppbc appears durably altered involution ppbc
166,Liver_Cancer,estimation prediction incidence mortality prevalence china objective estimate incidence mortality year prevalence rates china methods data registries third national death survey china used estimate incidence mortality year prevalence country using mathematical models predict incidence mortality next years results incident cases total number deaths total incidence rate ranking third among mortality rate ranking second among year prevalence total proportion ranking sixth among cases appeared men sex ratio male female terms deaths due occurred men sex ratio male female age group incidence mortality among males higher females happened frequently among people older years age particularly among males data
167,Liver_Cancer,siglec negatively correlated pd l hcc could induce cd cell apoptosis promote immune evasion functional roles siglec hepatocellular carcinoma hcc clear recently found immune inhibitor similar structure inhibitory b family members siglec expression hcc explored public databases examined pcr analysis siglec pd l expression patterns examined hcc samples immunohistochemistry siglec expression knocked expressed hcc cell lines cck tests used examine cell proliferative ability vitro influences siglec expression tumor growth examined immune deficient immunocompetent mice respectively co culture system hcc cell lines jurkat cells flow cytometry analysis tumor infiltrated immune cells sequencing analyses performed investigate siglec could
168,Liver_Cancer,galectin drives anti pd l bvz resistance regulating metabolic adaptation tumour associated neutrophils hepatocellular carcinoma abstracttext label background nlmcategory background combination atezolizumab bevacizumab atz bvz therapy significantly advanced therapeutic approaches hepatocellular carcinoma hcc however less patients achieve durable responses highlighting urgent need understand mechanisms underlying resistance abstracttext abstracttext label objective nlmcategory objective study aimed elucidate mechanisms resistance atz bvz therapy hcc identify druggable targets associated resistance thus improving treatment efficacy atz bvz resistant hcc abstracttext abstracttext label design nlmcategory methods employed single cell rna sequencing prospective clinical cohort nct identify characterise potential genes contribute atz bvz
169,Liver_Cancer,global burden primary predictions abstracttext label background amp aims burden varies across world herein present updated estimates current global burden incidence mortality provide predictions number cases deaths abstracttext abstracttext label methods extracted data primary cases deaths globocan database includes countries age standardised incidence mortality rates asrs per person years calculated cases deaths year predicted based incidence mortality rates global demographic projections abstracttext abstracttext label results estimated people diagnosed people died globally global asrs new cases deaths respectively per people highest eastern asia new cases deaths northern africa new cases deaths south eastern asia new cases deaths
170,Liver_Cancer,circrpn inhibits aerobic glycolysis metastasis hepatocellular carcinoma abstracttext although circular rnas circrna known modulate tumor initiation progression role hepatocellular carcinoma hcc metastasis remains poorly understood three metastasis associated circrnas identified previous circrna sequencing study screened validated two hcc cohorts circrpn downregulated highly metastatic hcc cell lines hcc tissues metastasis patients hcc lower circrpn levels displayed shorter overall survival higher rates cumulative recurrence mechanistic studies vitro vivo revealed circrpn binds enolase eno accelerates degradation promote glycolytic reprogramming akt mtor pathway thereby inhibiting hcc metastasis circrpn also acted competing endogenous rna mir p increases forkhead box protein foxo
171,Liver_Cancer,deep learning based analysis preoperative mri predicts microvascular invasion outcome hepatocellular carcinoma abstracttext label background nlmcategory background preoperative prediction microvascular invasion mvi critical treatment strategy making patients hepatocellular carcinoma hcc aimed develop deep learning dl model based preoperative dynamic contrast enhanced magnetic resonance imaging dce mri predict mvi status clinical outcomes patients hcc abstracttext abstracttext label methods nlmcategory methods retrospectively included total hcc patients pathologically confirmed mvi status preoperative dce mri patients collected annotated analyzed dl study predictive model mvi integrating dl predicted mvi status dl mvi clinical parameters constructed multivariate logistic regression abstracttext abstracttext label
172,Liver_Cancer,distinct immune microenvironment venous tumor thrombus hepatocellular carcinoma single cell resolution abstracttext label background aims nlmcategory objective portal vein tumor thrombus pvtt worsens prognosis hepatocellular carcinoma increasing intrahepatic dissemination inducing portal vein hypertension however immune characteristics pvtt remain unclear therefore study aims explore immune microenvironment pvtt abstracttext abstracttext label approach results nlmcategory results time flight mass cytometry revealed macrophages monocytes dominant immune cell type pvtt higher proportion primary tumor blood vs p lt differentially enriched clustering inhibitory regulatory immune cells pvtt indicated immune suppressive environment according single cell rna sequencing tam c ar characterized leukocyte chemotaxis
173,Liver_Cancer,postoperative circulating tumor cells predict benefits tyrosine kinase inhibitor hepatocellular carcinoma transplantation abstracttext label aim nlmcategory objective circulating tumor cells ctc shown promise predicting outcomes adjuvant treatments several malignancies clinical significance ctc predicting efficacy tyrosine kinase inhibitor tki administration patients hepatocellular carcinoma hcc unclear abstracttext abstracttext label methods nlmcategory methods total patients underwent transplantation hcc provided preoperative postoperative blood samples could used ctc detection pre ctc post ctc association pre ctc post ctc findings efficacy tki administration assessed additionally ctc surveillance performed patients tki administration abstracttext abstracttext label results nlmcategory results patients detectable post ctc instead
174,Liver_Cancer,tumor derived pd pd l could promote hepatocellular carcinoma growth autophagy induction vitro abstracttext label backgrounds autophagy tumor also found influence immune microenvironment relation autophagy intrinsic pd pd l expression clear abstracttext abstracttext label methods data tcga gtex databases mrna expression levels autophagy related genes compared tumor samples normal tissues also correlated survival status expression autophagy related genes also associated clinical traits datasets gse icgc liri single sample gene set enrichment analysis ssgsea used calculate autophagy scores tumor samples using signatures msigdb database lentivirus pd pd l sirna atg plasmids lc b used target specific genes
175,Liver_Cancer,unveiling oncogenic role lncrna h implications proliferation migration invasion epithelial mesenchymal transition jats title abstract jats title jats p objective study aimed investigate functional role long ncrna lncrna h tumorigenesis focusing effect cell proliferation apoptosis cell cycle progression migration invasion epithelial mesenchymal transition emt methods tissues cell lines analyzed lncrna h expression using quantitative methods functional role h assessed silencing expression cells cell proliferation evaluated measuring apoptosis induction cell cycle progression migration invasion capabilities cells assessed impact emt examined results significantly higher levels lncrna h observed tissues cell lines normal cells silencing h cells led notable
176,Liver_Cancer,jove video dataset lethality resistance chemical drugs forced search effective prescriptions traditional herbs animal models repeatable easy manipulate highly mimic pathophysiological processes prerequisite successful screening effective drug candidates meanwhile reliable drug efficacy evaluation indicators means also guarantee anti drug research development sanleng jiashen formula representative prescription traditional chinese medicine containing sparganium stoloni erum buch ham sanleng panax ginseng c mey ginseng rheum officinale baill rhubarb ligusticum chuanxiong hort chuanxiong prescribed nourish clear heat remove toxins promote blood circulation treat experimental protocol describes preparation lyophilized sanleng jiashen formula establishment process situ balb c nu mice histopathological staining
177,Liver_Cancer,mastl ybx pak axis regulated stress activated stk triggers lenvatinib resistance tumor progression hcc abstracttext label background aims nlmcategory objective many patients hcc present inadequate responses lenvatinib therapy therefore important elucidate underlying mechanisms resistance formulate effective reversal strategies abstracttext abstracttext label approach results nlmcategory results conducted transcriptome proteome sequencing analyses lenvatinib resistant cell lines patient derived tissues identifying microtubule associated serine threonine kinase like mastl critical factor associated lenvatinib resistance hcc utilized subcutaneous mouse models half maximal inhibitory concentration ic measurements colony formation assays determine biological function mastl promoting tumor growth mediating resistance lenvatinib elucidate underlying
178,Liver_Cancer,effects subtypes apolipoprotein e immune inhibition prognosis patients hepatocellular carcinoma abstracttext label purpose nlmcategory objective investigate whether prognosis patients hepatocellular carcinoma hcc affected abundance subgroups myeloid derived suppressor cells mdscs well subtypes expression apolipoprotein e apoe abstracttext abstracttext label methods nlmcategory methods hcc patients divided three groups according blood total apoe level detecting abundance immunoregulatory cells flow cytometry tumour tissue microarrays hcc patients evaluated abundance subgroups mdscs expression apoe apoe apoe immunofluorescence staining immunohistochemistry staining survival analysis means univariate multivariate cox regression kaplan meier methods patients performed based clinical pathological examinations along years follow data abstracttext
179,Liver_Cancer,adjuvant lenvatinib radical resection patients hepatocellular carcinoma hcc preliminary analysis prospective multi center single arm study jats p e jats p jats p background chinese guidelines recommend surgical resection patients china cnlc stage ia iiia hcc equal bclc stage b selected patients bclc stage c despite treatment however patients cnlc stage iib tumor number gt iiia vascular invasion disease high recurrence risk poor overall survival os assessed efficacy safety adjuvant lenvatinib patients high risk disease recurrence methods multi center single arm prospective clinical trial nct patients underwent radical r resection cnlc stage iib iiia hcc within
180,Liver_Cancer,fto downregulation mediated modification resulting enhanced hepatocellular carcinoma invasion abstracttext label background nlmcategory background dysregulation n methyladenosine modifications implicated various including hepatocellular carcinoma hcc study aimed elucidate role modifications hcc prognosis molecular mechanisms involved particularly focusing demethylase fto abstracttext abstracttext label methods nlmcategory methods analyzed expression cohort hcc patients using immunohistochemical ihc staining expression related genes fto alkbh mettl mettl evaluated qrt pcr paired hcc tissues established hcc cell lines altered fto expression assess impact cell proliferation invasion metastasis various vitro assays vivo orthotopic hcc mouse models statistical analyses included pearson chi square test kaplan meier
181,Liver_Cancer,efficacy safety toripalimab combined sorafenib unresectable hepatocellular carcinoma open label prospective single arm phase ii study jats p e jats p jats p background hepatocellular carcinoma hcc often diagnosed advanced stage leaving patients ineligible surgery sorafenib first line therapy disease progression still occurs patients within year toripalimab immune checkpoint inhibitor demonstrated promising efficacy safety various solid tumors combination sorafenib may alter outcomes hcc patients study aims assess safety efficacy toripalimab plus sorafenib treatment advanced hcc methods single arm open label prospective phase ii clinical trial nct patients unresectable hcc participants receive toripalimab mg iv sorafenib mg
182,Liver_Cancer,exploration link covid alcoholic hepatitis perspective bioinformatics systems biology jats title abstract jats title jats p severe acute respiratory syndrome coronavirus sars cov suggested purpose threats health mankind alcoholic hepatitis ah life threatening acute chronic failure takes place sufferers drink excessively epidemic ah increasing incidence severe illness mortality intrinsic relationship molecular pathogenesis well common therapeutic strategies two diseases still poorly understood transcriptome covid ah compared obtain altered genes hub genes screened protein protein interaction ppi network analysis via gene ontology go pathway enrichment transcription regulator analysis deeper appreciation interplay mechanism hub genes established finally gene disease
183,Liver_Cancer,fatty associated factors among breast patients dharmais hospital jakarta jats p background fatty frequently found ultrasound us examination breast patients known association breast fatty study aimed obtaine prevalence fatty breast patients association clinical characteristics patients method cross sectional study dharmais hospital jakarta study subjects breast patients came january december fatty assessed using abdominal us grouped mild moderate severe clinical characteristics patients included age body mass index bmi menopausal status breast tissue density using breast imaging reporting data system bi rads immunohistochemical estrogen receptor er status results total patients enrolled study period mean age years fatty found
184,Liver_Cancer,depth radiographic response independent prognostic factor patients initially unresectable hepatocellular carcinoma receiving hepatectomy following targeted therapy plus immunotherapy abstracttext label introduction nlmcategory unassigned surgical resection following systemic therapy feasible patients initially unresectable hepatocellular carcinoma hcc however postoperative tumor recurrence common surgery factors affecting recurrence remain unclear study aimed assess factors influencing postoperative outcomes patients initially unresectable hcc undergoing hepatectomy systemic therapy abstracttext abstracttext label methods nlmcategory unassigned study retrospectively enrolled patients initially unresectable hcc underwent hepatectomy targeted therapy plus immunotherapy without locoregional therapy multivariate cox regression analyses used identify independent prognostic factors recurrence free survival rfs
185,Liver_Cancer,global incidence mortality relationship human development index hdi ecology study introduction one important intensifying challenges global health especially developing countries aim study evaluate epidemiology incidence mortality countries determinate relationship human development index hdi materials methods present study descriptive cross sectional study based extraction incidence data mortality rates world bank incidence mortality rates distribution maps drawn world countries analyze data correlation test regression tests used evaluate correlation incidence mortality hdi statistical analysis carried stata significance level estimated level results according results record cases recorded cases related highest incidence mortality asia countries mongolia egypt results showed negative correlation
186,Liver_Cancer,sintilimab combined bevacizumab biosimilar conversion therapy potentially resectable intermediate stage hepatocellular carcinoma hcc updated results phase ii trial jats p e jats p jats p background combination sintilimab pd antibody bevacizumab bev biosimilar improved progression free survival overall survival unresectable advanced hcc compared sorafenib orient study approved first line treatment unresectable hcc china assessed efficacy safety combination therapy conversion therapy potentially resectable intermediate stage hcc methods treatment na patients pts potentially resectable intermediate stage bclc stage b hcc enrolled phase ii trial nct eligible pts received sintilimab mg iv bev mg kg iv per weeks tumor
187,Liver_Cancer,evaluating prognostic value biliary stone intrahepatic cholangiocarcinoma propensity score matching analysis b background b explore biliary tract stone bts prognostic factors intrahepatic cholangiocarcinoma icc b methods b clinical data icc patients classified bts group bts group subgrouped hepatolithiasis hl non hepatolithiasis nhl group propensity score matching utilized mitigate baseline characteristics preoperative peripheral inflammation parameters ppip investigated immunostaining cd cd cd cd pd pd l conducted b results b overall survival os patients without bts surpassed bts group p difference time recurrence ttr observed p hl group shorter os ttr hl matched group p p respectively survival
188,Liver_Cancer,bevacizumab combined atezolizumab sintilimab second line treatment patients advanced hepatocellular carcinoma retrospective study jats p jats p jats p background combination bevacizumab immune checkpoint inhibitors ici demonstrated promising efficacy safety first line treatment advanced hepatocellular carcinoma hcc however combination examined patients previous first line treatment ici tyrosine kinase inhibitor study aimed investigate effectiveness safety bevacizumab combined atezolizumab sintilimab second line treatment patients advanced hcc methods retrospective study included patients advanced hcc received combined therapy bevacizumab atezolizumab sintilimab failure lenvatinib plus ici july march baseline patient characteristics collected treatment response overall response rate orr disease control rate
189,Liver_Cancer,expression clinical significance lag fgl pd l cd cells hepatocellular carcinoma using multiplex quantitative analysis jats title abstract jats title jats p background fgl lag pathway promising immunotherapeutic target synergistic effect pd pd l however prognostic significance fgl lag pathway correlation pd l hepatocellular carcinoma hcc remain unkonwn method distributions associations clinical significances lag fgl pd l cd protein expression hcc patients assessed multiplex immunofluorescence results found fgl lag densities elevated pd l cd decreased hcc tissues compared adjacent normal tissues high levels fgl strongly associated high densities lag cells pd l cd cells densities positive
190,Liver_Cancer,primary diffuse nodular multiple nodules type ct manifestations metastatic objective discussion analysis primary diffuse nodule multiple nodules patients metastatic ct manifestations diagnostic value summarizes experience method selection january december hospital diagnosis treatment patients primary diffuse nodular cases multiple nodules patients metastatic research object clinical data study object ct scans collection analysis summarized experience diagnosis result finishing found primary diffuse nodules patients ct performance main characteristics follows scan enhanced scanning lobe volume ratio significantly abnormal disproportionate scan lobe isodensity diffuse low density nodules fuzzy boundaries enhanced scan part lesion appear obviously improved show cricoid improved multiple nodules
191,Liver_Cancer,identification driver mutations cosmic data jats p background accounts deaths year making third leading cause related deaths worldwide late diagnosis disease reason behind deaths driver mutations genetic alterations tumor cells responsible development therefore identification genetic biomarkers necessary prediction early diagnosis objectives main objective study identify pathogenic alleles may act potential biomarkers prediction also identifies role novel genes known cause disease methods mutation data non coding variants downloaded catalogue somatic mutations cosmic databases different bioinformatics tools used retrieve mutations genetic alterations hepatocellular carcinoma hcc analyzed results present study successfully identified pathogenic alleles consistent mutations along set novel
192,Liver_Cancer,data berbamine inhibits growth cells initiating cells targeting ca sup sup calmodulin dependent protein kinase ii jats p lt div gt abstract lt p gt third leading cause deaths worldwide effective treatment toward available far therefore unmet medical need identify novel therapies efficiently treat improve prognosis disease report berbamine one derivatives bbd potently suppressed cell proliferation induced cell death targeting ca lt sup gt lt sup gt calmodulin dependent protein kinase ii camkii furthermore berbamine inhibited lt gt vivo lt gt tumorigenicity cells nod scid mice downregulated self renewal abilities initiating cells chemical inhibition short hairpin
193,Liver_Cancer,inhibitory active dual targeting fluorouracil nanoparticles vitro vivo jats title abstract jats title jats p previous experiments biotin bio grafted onto cs synthesize biotin modified chitosan bio cs targeting efficacy still room improvement targeting bio cs based high expression folate fa receptors surface fa grafted onto bio cs chemical synthesis optimize synthesis folic acid modified biotinylated chitosan fa cs bio verified infrared spectroscopy jats sup jats sup h nmr fa cs bio fluorouracil fu nanoparticles obvious sustained release effect compared bio cs fa cs bio could promote inhibition proliferation migration fu concentration fu hepatoma cells significantly
194,Liver_Cancer,cause death cause specific mortality primary south korea nationwide population based study hepatitis b virus endemic area abstracttext label background aims primary one leading causes mortality worldwide however causes death studied detail patients abstracttext abstracttext label methods causes death cause specific mortality risks patients primary diagnosed investigated using nationwide population based registry data south korea n cumulative incidence function fine gray models used estimate cause specific mortality competing risks risks non deaths relative general population compared standardized mortality ratios smrs abstracttext abstracttext label results among total deaths patients died primary sites non illnesses respectively proportionate mortality
195,Liver_Cancer,levels serum markers rat model versus elderly patients objective detect expression levels serum alpha fetal protein afp carbohydrate antigen ca carcinoembryonic antigen cea rat model elderly patients explore clinical significance methods rat model successfully established intraperitoneal injection low dose diethylnitrosamine den expression levels serum afp ca cea rats determined compared development blood samples collected elderly subjects normal elderly patients n expressions serum afp ca cea determined compared healthy elderly patients elderly patients results serum levels afp ca cea higher rats normal rats g l vs g l ku l vs ku l g l vs g
196,Liver_Cancer,malbi child pugh based nomogram predicting post hepatectomy failure grade b c patients huge hepatocellular carcinoma multi institutional study abstracttext label objective nlmcategory objective post hepatectomy failure phlf severe complication patients hepatocellular carcinoma hcc underwent hepatectomy study aims develop nomogram phlf grade b c patients huge hcc diameter cm abstracttext abstracttext label methods nlmcategory methods retrospectively collected clinical information patients underwent hepatectomy huge hcc two medical centers univariate multivariate analysis carried screen independent risk factors phlf grade b c visualized nomogram abstracttext abstracttext label results nlmcategory results three hundred forty three thousand one hundred seventy one
197,Liver_Cancer,monocarboxylate transporter inhibition potentiates hepatocellular carcinoma immunotherapy enhancing cell infiltration immune attack abstracttext label background aims monocarboxylate transporter mct high affinity lactate transporter primarily involved maintenance intracellular ph homeostasis highly expressed different tumors however role mct modulating immune responses hcc remains unknown abstracttext abstracttext label approach results study demonstrated mct overexpressed hcc associated poor prognosis patients genetic pharmacological inhibition mct using vb highly potent mct inhibitor suppressed hcc tumor growth immunocompetent mice model enhancing cd cell infiltration cytotoxicity improved immunotherapy response mct targeting due combined consequences characterized alleviated acidification tumor microenvironment elevated chemokine c x c
198,Liver_Cancer,criteria identifying potentially resectable patients initially oncologically unresectable hepatocellular carcinoma treatment lenvatinib plus anti pd antibody abstracttext label background nlmcategory unassigned conversion therapy feasible patients oncologically unresectable hepatocellular carcinoma hcc however challenging prospectively identify patients likely achieve successful conversion initiating systemic therapy either alone combined locoregional therapy abstracttext abstracttext label methods nlmcategory unassigned criteria identifying potentially resectable patients initially oncologically unresectable hcc treatment lenvatinib plus anti pd antibody proposed based real world evidence multivariate firth logistic regression used validate proposed criteria retrospective cohort consecutive patients advanced hcc received combination therapy lenvatinib plus anti pd antibody september
199,Liver_Cancer,safety profile hepatectomy following preoperative systemic therapy lenvatinib plus anti pd antibodies versus hepatectomy alone patients hepatocellular carcinoma abstracttext label objective nlmcategory unassigned determine safety hepatectomy combined lenvatinib anti pd preoperative systemic therapy pst patients marginally resectable hepatocellular carcinoma hcc abstracttext abstracttext label background nlmcategory unassigned pst followed hepatectomy psth emerging treatment hcc however impact pst lenvatinib plus anti pd antibodies surgical safety unknown abstracttext abstracttext label methods nlmcategory unassigned medical records consecutive patients marginally resectable advanced hcc underwent hepatectomy pst lenvatinib anti pd antibodies january august retrieved prospectively designed database propensity score matching performed hcc
200,Liver_Cancer,conversion therapy initially unresectable hepatocellular carcinoma using combination toripalimab lenvatinib plus tace real world study abstracttext label background combination conversion therapies afforded curative surgery chance initially unresectable hepatocellular carcinoma uhcc study aimed evaluate conversion rate clinical outcomes first line conversion regimen lenvatinib combined transarterial chemoembolization tace plus immunotherapy initial uhcc interpreting real world data abstracttext abstracttext label methods conversion therapy data patients uhcc november january analysed regimens included triple combination therapy ct lenvatinib tace plus toripalimab dual combination therapy ct lenvatinib plus tace another study population diagnosed hepatocellular carcinoma macrovascular invasion disease included upfront surgery cohort
